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1 Introduction 
There are striking differences in innovation performance between Japanese, American, and 
European fmns. For example, even though the cost per time unit of the innovation process 
seems to be lower in Germany than in Japan, total cost of an innovation is significantly 
higher in German than in Japan~se firms due to longer innovation periods.• Thus, it is not 
surprising to still observe concerns about the innovative performance of European 
companies. But structural changes are already under way within Europe's chemical 
industry, whereby corporate concentration on innovative lines of business is of major 
importance. Thus, the individual companies'· innovative capabilities have ·turned into the 
most decisive factors for their successful competition. 
This study illustrates by means of nine selected European chemical companies those areas 
of the chemical industry currently holding high innovative potential and at the same time 
reveals the relevant innovative and corporate strategies dominating today's chemical 
companies. Furthermore it is using data from the Community Innovation Survey (CIS) to 
describe and explain the differences of innovative performance across fmns within the 
European chemical industry. 
A 'wide interpretation' of the term innovation is used, which includes the whole of the.· 
innovation process-from the analysis of a problem, the search for ideas, research and 
development (hereafter referred to as R&D), production and sales preparations, to the 
introduction of a new product or procedure into the market New is used in the sense of the 
so-called relative novelty defmition and includes any company oriented novelties, which 
. . . 
means that even a renewned procedure being purchased by a company, e.g. by way of 
taking out a licence, constitutes an innovation for this p~rticular company.2 
Most innovations in ~e chemical industry originate from· so-called internal sources, i.e. 
mainly from company-owned R&D departments. Decisions on the orientation of the 
corporate R&D activities, as well as on the allocation of R&D resources and capaciues, are 
made within the framework of the respective technological and innovative strategies. 
•For a discuss~on of these problems see e.g. Albach, H., Culture and Technical. Innovation - A Cross-Cultural 
Analysis and Policy Recommendations, in: Akadmie der Wissenschaften zu Berlin, The Academy of Sciences 
and Techoology in Berlin, Research Repon 9, Working Group Culture and Technical Innovation, Culture and 
Technical Innovation-- A Cross-Cultural Analysis and Policy Recommendations. Berlin: Walter de Gruyter, 
1994, pp.1-597. See e.g. Acs and Audretsch (1990) for an analysis of the US industry. 
2 See e.g. Albach ( 1994 ), p. 50-54 and in panicular for the chemical industry Schmidt ( 1991 ), p. 7 
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2 The Chemical Industry 
2.1 · Products and Industry Structure 
The chemical industry3 is the third largest manufacturing industry in the EU and certainly 
one facing a paramount challenge regarding its innovative activities. The industry 
comprises all companies producing their products exclusively or mainly by way of the 
conversion of substances. The goal of chernisn:y as such is the substitution of natural 
substances and/or th~ creation of new substances. This is done either by the conversion of 
natural substances (such as modified starches) or by the syntheses of organic or inorganic 
base material (i.e. the synthesis of chlorinated dissolvents). Companies whose treatment of 
substances is done exclusively by (or connected with) physical processes, such- as mixing, 
emulsifying or extracting are also often considered to be part of the chemical industry.4 
The chemical industry differs from other lines of industry mainly through the heterogeneity 
of its products. As a result, the individual line segments are subject to completely different 
technical/scientific conditions as well as different R&D situations. · Thus, SchulzeS 
describes chemistry as a sum of individual lines of industry. 
3 For a description, data, and analyses of the chemical industry see e.g. the following publications: EC 
Commission (ed.), Panorama ofEC Industry, Brussels/Luxembourg, 1994, and Freeman, C., Chemical 
Process Plant: Innovation and the World Market, in: National Institute Economic Review, No.45 (August), 
1968, pp.29-51; Backman, 1., Economics of Chemical Industry, Washington, D.C., 1970; Kolbel, H., 
Schulze, J ., Der Absatz in der chemisehen Industrie, Berlin, 1970; Albach, H., Kloten, N ., Gutachterliche 
Stellungnahme zu der Preispolitik auf dem Farbstoffmarkt in der EWG in der Zeit von 1964 bis 1967, 
TUbingen, 1973; Reader, W J., Imperical Chemical Industries, a History, 2 volumes, Oxford University Press, 
1970, 1 97:'i; Dirrheimer, M., Vertilcale Integration in der MineraltU-lmd Chemischen Industrie, Meisenheim 
am Glan, 1981; Legler, H., Intemationale Wettbewerbsflihigkeit der westdeutschen Chemischen Industrie, 
Berlin, 1982; Taylor, G.D., Sudnik, P .E., DuPont and the International Chemical Industry, G.K. Hall, 
Boston, MA, 1984; Streck, W.R., Chemische Indusirie. Strukturwandlungen und Entwicklungsperspektiven, 
Berlin, 1984; Servatius, H.-G., Methodik des strategisctien Technologie-Managements. Grundlage fiir 
erfolgreiche Innovationen, 2nd ed., Berlin, 1986; Lieberman, M., Patents, Learning by Doing, and Market 
Strut;ture in the Chemical Processing Industries, in: International I oumal of Indus trW Organization, Vol.5, 
1987, pp.257:-276; Hounshell, D.A., Smith,I.K., Science and Strategy: DuPont R&D, 1902-1980, 
Cambridge University Press, 1988; Spitz, P.H., Petrochemicals: The Rise of an·Industry, New York, 1988;· 
Stokes, R., Divide and Prosper: The Heirs ofiG Farben under Allied Authority 1945-51, University of 
California Press, Berkeley and London, 1988; Lieberman, M., The Learning Curve, Technological Barriers to 
Entry, and Competitive Survival in the Chemical Processing Industries, in: Strategic Iotimal, Vol.lO, 1989; 
Maynard,I.T., Peters, H.M., Understanding Chemical Patents: A Guide for the Inventor, American Chemical 
Society, Washington, D.C., 1991; Landau, R., Rosenberg, N., Successful Commercialization in the Chemical 
Process Industries, in: Rosenberg et al. (eds.), Technology and the Wealth of Nations, Stanford University 
Press, 1992; Liebenau,I., The Management of High Technology: The l]se of Information in the German 
Chemical Industry, 1890-1930, in: Kudo, A., Hara. T .• International Cartels in Business History, University 
ofTokyo Press, 1992; 
4 Cf. Amecke, p. 13 
S Cf. Schulze, p. 6 
4 
industrial clients. Furthermore, as a result of the high degree of vertical integration within 
the chemical industry, 36 percent of the demand for c~emical products originates from the 
chemical industry itself.6 Other major consumers of the chemical industry are automobile 
manufacturers, the construction industry and agricultural industries. 
Nowadays, a so-called product-group. matrix (see Figure 2.~) prevails for the crude 
classification of chemical productS. Four product groups are distinguished in accordance 
with the two dimensions of production quantity and differentiation level. Each of these 
groups shows specific characteristics that need to be observ~ in strategic planning. The 
models introduced in the previous section and the ensuing hypotheses can be ascertained by 
way of said product-group matrix. It is generally assumed that the following applies to the· 
model of the product life cycle: 
• .For base chemicals, sometimes even for fine chemicals, the curve simply flattens in 
the stage of maturity and then stagnates, thus preventing a drop. 
• For industrial and special products, however, the typical ·ideal curve applies, i.e. 
towards the end of the product life cycle the run of the curve begins to slope. 
Output 
high 
low 
Basic Chemicals: I Industrial Chemicals: 
I 
process development and improvement j process developments and improvements 
and only some product developments I and only some product developments 
Fine Chemicals: ·.. I Specialty Chemicals: 
I . 
product and process developments ~d I produc~ developments and improvements 
low 
' improvements I ~only some process developments 
I 
high 
Degree or differentiation 
Source: Schmidt. p. 150 
Figure 2.1 Product-Group Matrix 
6 Cf. Particulars from European Commission, p. 6-5 
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The product-group matrix permits conclusions concerning the business concentrations 
within the individual product groups. Due to their high degree of capitalisation, the base 
chemicals are produced by the major companies. Fine chemicals, on the other hand, and 
specialized products, above all, are produced by medium and small fmns. Table 2.1 shows 
that the chemical industry is a fairly concentrated line of industry--although a certain 
balance between major companies and smaller firms prevails. For instance, the 10 leading 
Ell-companies hold 48.6 percent of the entire industrial turnover; the five leading ones 
represent 32.6 percent of the tumover.7 
Table 2.1 Concentration of the Chemical Industry within the European Union 
Total- Total %of all %of all % ofEU-
·Employees Com_panies Companies Employees Turnover 
less than 20 25,366 77.6 7.2 11.4 
20-99 4,748 14.5 10.6 9.6 
100 and above 2,595 7.9 82.2 79 
Source: Em:opean Commission, p. 6-6 
2.2 Typical Life Cycles: Two Examples 
Products, technologies, and industries can be described in their respective life cycles. It is 
assumed that the chemical industry has already left its growth phase 'because of the 
following developments in th~ history of chemistry. 
Since the beginning of the century, . the chemical industry has been growing at a 
disproportionately high rate. Even between 1970 and 1990, the European chemical industry 
grew by 10 percent, while general productive industry reached· a mere 2 percent.8 This is 
mainly due to the substitution of traditional materials, such as wood, steel and glass, by 
chemical products--a development that was only made possible through continuous 
7 Cf. European Commission, p: 6-5 
8 Ibid 
6 
introduction of new products and pt:ocedures. Since this has always called for high research 
expenses, the chemical industry is considered an extremely R&D-intensive one. 
Some authors9 see the explanation for the development of the chemical industry in so-
called waves, triggered by certain basic innovations. According to Franck, the following 
innovations constituted revolutionary basic innovations: the production of mineral fertiliser 
in the frrst half of the 19th century, the introduction of the Haber-Bosch-process, the 
synthesis of organic colorants, and the development of plastics (the scientific foundation of 
which had already been laid in the 1920s and 1930s). Amecke, however, and the DRI 
Europe to argue that today the potential for further development of basic innovations made 
in the past is exhausted. Despite increasing R&D expenses (EU average at 4.8 percent of 
the turnover), the chemical industry is currently in a phase with little innovative 
opportunities. Whether or not the development of gene techitology currently under way will 
be able to instigate a new upsurge in the chemical and pharmaceutical industries remains to 
be seen. 
Figure 2.2 shows the life cycles (S-curves) for different processes for the manufacture of 
cord for tires. Due to differences in their technological potential substitution took place. 
Decreasing returns to cumulative R&D effort is evident For example, the investment of the 
frrst 60 million US $ before 1962 has led to an improvement of the relative cord 
performance of 800 percent whereas the next 15 million US $ led only to an increase of 25 
percent, and the fmal25 million US$ to a performance increase of about 5 percent only. At 
the same time the nylon technology surpassed the performance of the rayon technology, but 
it ~ached its performance limit soon. Then the polyester technology took the lead. Thus it 
is obvious that the existence of decreasing returns to R&D in the chemical industry , 
intensifies the 'search of fmns for new technologies. , 
Another example is fmn-specific and relates to the BASF portfolio of polymeric materials. 
Figure 2.3 shows the position of various polymeric material within the a 10 years, life cycle. 
The performance is defllied as market performance, that is the ann~ growth of outp~t 
over the 10 years , period. The circles are indicating the market volume of the particular 
material. The black circles are speciality polymeric material whereas the white Ci:cles are 
indicating the standadrd materials. The standard materials are in a more mature stage of the 
life cycle but they exhibit a considerably larger market volume. This simple moqel would 
advise the fmns to invest R&D frrst of all into emerging technologies, that is into speciality 
I ' 
i 
i 
, I 
' 
chemicals but also in basic innovations in their respective areas of competence. 1 
1 i 
, I 
I 
9 cf. Mensch; Franck; Ayres 
10 Cf. European Commission, p. 6-8 
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Figure 2.2 Life Cycles for Different Processes for the Manufacture of Cord for Tires 
(Source: Ayres. p. 104) 
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Figure-2.3 Stage of Product Life Cycle for Various Polymeric Materials 
(Source:(2uadbeck-Seege~p.5) 
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Corporate orientation towards specialized chemistry can also be considered to substantiate 
the theory of poor innovative opportunities. Specialized chemi~try is characterized by 
higher profit margins and lower competitive pressure. It is highly influenced by clients' 
needs; very often, however, variations of already existing products are in the fore. The 
explanation for the distribution of R&D expenses as per Table 2.2 can also be found in this 
trend towards specialization. Similarly, the partial increase in product development can be 
explained by the above statement according to which the innovations in the specialized 
industry concern almost exclusively products. The fact that these product innovations are 
very often nothing but product variations or further developments of existing products is 
substantiated by the high and slightly increasing amount of R&D expenses for development 
shown in Table 2.2. 
Table 2.2 Distribution of R&D Expenditures of German Chemical Firms According 
to Product and Process Innovation and by Innovation Significance 
(in percent) 
Type of Innovation 1977 1987 1989 1991 
Product Innovations 73.8 78.2 77.6 82.5 
Process Innovations 26.1 21.8 22.4 "18.0 
Innovation Significance 
Incremental Innovations 52.2 54.7 50.7 55.5 
Major Innovations 47.8 45.3 49.3 44.5 
So1irce: SV-Wissenschaftsstatistik, pp. 38-39 
9 
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3 Measurement of Innovation Trends 
3.1 The Measurement Approach 
The subjects of the 10-year investigation at hand are nine selected European chemical 
c~mpanies. Apart from company size being a decisive factor in the selection of the relevant 
companies, the selection was also carried out with the goal of obtaining a broad r:ange of 
chemical lines and a certain diversity in strategic orientation. 
The annual reports of the respective companies, which are published annually, supply the 
relevant basic data. The followj.ng report items are investigated: 
• Product and process innovations, which are then described in detail by means of a 
specially designed system; 
• Quantitative data regarding R&D activities, such as R&D expenses and the number 
of employees involved in R&D; 
• Quantitative data regarding corporate success and growth; 
• Qualitative data regarding the strategies pursued by the individual lines of industry. 
3.2 Selectio~ of the Companies to be Investigated 
The selection of the companies to be investigated was made according to their sizes and 
their lines of industry. In order to cover as many innovations as possible, and thus achieve 
results of the most accurate representativeness possible regarding prevailing trends in 
innovation, the major European chemical companies were chosen for the investigation. 
Table 2.3 show.s .t.h~ )t":ading 15 F.nropean chemical companies, aiTanged in order of their 
total economic turnover (this ranking· causes certain distortions, since the shares of 
chemicals in the individual turnovers may well differ in size; e. g. ICI shows a higher 
engagement in the chemical line than Sandoz). . 
From these 15 companies, nine were selected according to corporate proftle and the 
availability of annual reports (see last column). Bayer and ICI represent the big, bro~ly 
diversified companies, while Ciba-Geigy and Sandoz stand for the specialized companies. 
Solvay and BASF, on the other hand, are more involved in basic chemicals. The innovative 
strategies of these companies are primarily dependent on their corporate know-how. This 
know-how, very often found mainly in the central areas of a company, is often the result of 
decades of R&D and, at the same time, a component of the corporate history. Therefore, a 
brief characterization of the companies under investigation is included in the appendix. 
10 
Table 3.1 The 15 J.,eading European Chemical Companies - 1992 
Company Country . Turnover Staff Selected 
inm ECU for study 
Hoechst D 22727 177 668 yes 
BASF D 22060 123 254 yes 
Bayer D 
I 
20411 156 400 yes 
ICI UK 16 388 114000 yes 
Ciba-Geigy CH 12 221 90554 yes 
Rhone-Poulenc F 11938 83300 
-
Sandoz CH 7935 53 360 yes 
Akzo NL 7 414 62500 yes 
NorskHydro N 7 236 34036 -
Roche Holding CH 7129 56335 -
Smithkline Beecham UK 7091 53700 
-
Henkel D 6987 42244 yes 
·Solvay & Cie B 6 125 45 350 yes 
Glaxo Holdings UK 5 801 37 083 
-
L'Oreal F 5489 31908 -
Source: European commission, p. 6-7 
3.3 Annual Reports as a Source of Information 
Annual reports are bound to-represent the economic situation of their respective compa.nles 
in such a manner that the companies' true conditions are clearly reflected. This also applies 
to expected corporate developments. Since the. prospective developments of. research-
intensive companies, such as chemical companies, .very much depend on ~&D, German 
law requires R&D. reports. The German chemical association therefore recommends the 
declaration of the following data: 11 ( 1) R&D areas and R&D facilities, (2~ R&D personnel 
and R&D expenses, (3) relevant results of R&D activities, as well as (4) the main R&D 
objectives. Germany's . major chemical companies comply with these recommendations, 
while, in <>ther countries, most annual reports _are less detailed. 
Usually, the amount of R&D expenses can be taken from the annual reports, which also 
supply the relevant data on turnover, balance-sheet total, annual net earnings and the 
respective operating results. 
The most important source of information for the study at hand, however, is the status 
report, ~hich is the main supplier for qualitative data on corporate and innovative 
11 Cf. Graumann, p. 194 
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strategies, as well as data on the major results and goals of R&D activities. This makes the 
status report the main source of information for the innovation counting underlying the . 
study at hand. 
3.4 Indicators of Innovative Activity 
Indicators for the Rating of Innovative Activities The quantitative display of corporate 
innovative activities is only possible by means of indicators, which in the form of so-called 
'representative variables' represent the unimaginable variable of 'innovative activity' more· 
or less accurately: Because of the diversity of the innovative process as such, the indicators 
are split up into input indicators and output indicators. Typical input indicators include the 
number of R&D personnel or the amount of R&D expenses. Established output factors 
include the .rate of product _innovation (products newly introduced into. the range of 
products· over the past 5 or 10 years), the number of patents granted, the frequency of 
citation in scientific publications and the counting of innovations. 
Input Indicators for the Rating of Research Expenses Various studies use the input 
indicators of R&D expenses and R&D personnel. The indicator of R&D personnel, 
however, has a certain disadvantage. In companies ~ith capital-intensive R&D, the 
relevant R&D expenses are easily underestimated, while in com_panies with personnel-
intensive R&D, an overestimation of these activities takes place. In addition, due to 
industrial reasons, R&D personnel can only be adjusted to changed R&D strategies after a 
certain time-lag. An additional advantage to using R&D expenses versus R&D personnel is 
the fact that by incorporation of outside services (such as R&D services carried out on 
order by third parties) the innovation input can be rated in a more complex ma.nrier. 
R&D (Expense) Intensity is calculated by the division of the R&D expenses by the 
relev:mt turnover, or bala.'lce-sheet total, respectively. The turnover-related R&D expense 
intensity is the·indicator more commonly used, while the expense intensity relating to the 
balance-sheet totals shows greater resistance to market swings.t2 
R&D Personnel Intensity is the quotient of the number of R&D personnel and i.he total 
number of employees. 
Output Indicators for the Rating of Research Success The R&D output indicator best 
known and most· easily accessible is the number of patents granted to a certain company. 
As an indicator, however, it also has two distinct disadvantages. First, the number of 
· patents granted is but a poor reflection of the underlying innovations, since only a small 
number of patents are actually put to economic use. Second, the inclination towards 
patentation varies greatly among the different companies and lines of business. In some 
12 Cf. Scbwitalla, p. 225 
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cases, inventions are never put up for patentation because other strategies, such as secrecy 
or an early market introduction, are given priority. 
Our study uses therefore the number of innovations recorded in the annual reports as an 
output indicator. This indicator is characterized by greater proximity to the market and, 
thus, attaches greater stress to the economic aspect of innovation. 
Financial Ratios for· Corporate Success Corporate success is generally. quoted in the 
form of profitability, cash-flow and profit-source analysis. This study uses the net profit 
ratio, as one of the most commonly used fmancial ratios, and on an analysis of the 
operating result. The net profit ratio is defmed as follows: 
• net profit ratio = annual net earnings * lOO 
turnover 
An examination of the operating result is significant in so far, as it reflects only the result 
of the corporate effort, at the same time ignoring fmancial and participation results and 
taxes. The operating result is used to .evaluate the profitability of the individual lines of 
business. 
Financial Ratios for Corporate Growth We characterizes corporate ·growth by means of 
the annual turnover growth rates, balance-sheet totals, R&D expenses, R&D personnel and 
increases in the total numbers of employees. 
3.5 Th~ Classification System for the Recording of Innovations 
The classification of individual innovations is done according to the product groups most 
commonly used in· the chemical industry. However, a categorization as per Standard 
International Trade Classification (SITC, 3rd revision) or NACE system was net possible. 
On the one hand, the data concerning process and product innovations in the an!!Ual·reports 
were not detailed enough to carry out an exact classification into the given product groups. 
On the other hand, the number of innovations under investigation was too smcll for a 
meaningful classification into the very specialized product groups of the 'srrc or NACE 
systems. As a result, new classifications of the existing material on the· basis of prevalent 
categories (such as SITC, NACE, relevant literature) were developed during the course of 
the evaluation. 
The new classification system was developed in connection with a pilot study and then 
further refmed during the course of the evaluation of the annual reports. The pilot study 
investigated two annual sets (1988 and 1993) of the periodical "Europa Che~ie," recording 
135 innovations. The present study uses the pilot ·study to investigate the quantitative 
results of the innovation counting from the various annual reports. 
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Our classification comprises nine key groups, som of which are divided into sub-groups, 
thus enabling both a. significant investigation of th material at hand and an identification 
of certain innovative trends. In addition, innovatio s are divided into product and process 
innovations and records are kept as to possible eco olitical innovations. 
The Classification System: 
0 Environmental Technologies: This c~tegory includes mainly recycling 
technologies. ~ese constitute a relatively new sphere of operation within the 
chemical industry, where repeatedly innova ons are recorded, but do not fit 4tto the 
traditional classification for chemical proc ses and products, so that this special 
category had to be introduced. Howeve , this group also inCludes recycling 
technologies that are mainly used for· the rec very of precious raw materials (such as 
platinum from catalysers) and are of a less e apolitical nature. 
1 Basic Organic Materials: Category No. contains chemical elements, as well as 
intermediate products, produced in large q antities, manufactured from crude oil, 
natural gas or . coal. This includes ethanol, · ethene, benzole, butadiene, 
2 
chloroethylene, and unwlcanized rubber. 
Basic Inorganic Materials: Catego 
manufactured in large quantities, which ar 
syntheses, such as ammonia, soda and sulph 
No. 2 includes inorganic elements 
needed as source material for various 
·c acid. 
3 Plastics: Because of the complexity and h terogeneity of this subject, a further sub-
division was attempted. However, the artiality and insufficiency of detailed 
information in the annual reports presen a problem to the realization of such 
classification. Finally a division was made · to: 
4 
30 Plastics that do not fit into either 31 o 
31 Traditional Mass Produced PI tics, such ~ . polyvinyl chloride, 
polyethylene, polystylene, polypropyl ne, as well as any new developments on 
the basis of mass produced plastics. 
32 Special Plastics, which are not base on traditional synthetic substances, such 
as polyetherketones, polyester·resins, polysulfones, polyurethane, polyacetals, 
polycarbonates, and copolymers. 
Synthetic Fibres: This category contains synthetic fibres including fibres based 
on natural substances, such as cellul se (viscose, acetates, etc.). Its major 
coQ.tponent, however, consists of polyamid and polyester fibres. 
5 Paints, y arnishes: Category No. 5 camp · ses both organic and inorganic colorants. 
Besides paints and varnishes, various coa ngs which are put to use as architectural 
14 
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7 
coatings, electrical insulation and in the automobiles industry also belong in this 
-group. 
Agrochemicals: Category No.6 includes fertilizers, plant protectives and veterinary 
preparations. Plant pro~ctives include insecticides, herbicide~. fungicides, pesticides, 
and plant growth regulators. 
Detergents, Cleaning materials and. Preservatives: This category include$ 
detergents, cleaning materials, preservatives, disinfectants and anti-corrosives for 
domestic and industrial use . 
. 8 Speciality Chemicals: As ·a result of its heterogeneity and. its importance 
concerning current innovative trends this category was split into the following sub-
groups: 
9 
81 Glues and Adhesives 
82 Petrochemical Additives: · Additives for the production of crude oil, fuel 
additives, etc. 
83 Finishing Agents for Textiles and Lea ... er 
84 Paper Chemicals; Specialities for the Printing Industry 
85 Specialities for Photographic Purposes 
86 Specialities for Information and Entertainment Technology 
· 87 Products for the Construction Industry 
88 Plastic Additives: Softening agents, antioxidant agents, etc. 
89 Miscellaneous: Examples are: lubricants. explosive substances, industrial 
gases. 
New Materials: The defmition of this category is particularly problematic, since 
numerous so-called special plastics would also have to be included. In order not to 
mix up different product groups, we include here only those products that do not fit 
into any of the categories already described above. Accordingly,. this category 
contains high-tech ceramics .and special purpose glasses, but no modem polymers. 
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4 Innovation Trends I: ~n Analysis f Innovation Counting Data 
4.1 An Analysis of Innovative Tren 
The following section evaluates the resul~ from the innovation counting, as well as the 
companies' success and fmancial ratios. The r ults .from the innovation counting are 
examined separately for the individual lines of usiness. The most innovative lines are 
identified along with the relevant exempl technological trends dominating the 
innovative activities in those lines. The extent. o ecopolitically motivated innovations is 
also investigated, as is any progress where tee ological developments in the area of 
environment protection were triggered. 
Apart from investigating the individual lines of business on the basis of the respective 
mean values of the past ten years, the study at han attempts to describe any tendencies that 
· may have appeared during the investigation pe · od (1984 - 1993), i. e." those lines are 
identified whose innovative frequency was subje t to change during the course of the ten 
years in question. This is done by means of a com arison of the innovative frequency of the 
respective fields at the beginning of the investiga on period (1984/85) and at the end of the 
investigation period (1992193). 
4.1.1 An Analysis of Innovative rends by Lines of Business 
The evaluation of 1,299 recorded innovations sh ws that the areas of speciality chemicals, 
paints and varnishes, and plastics comprise the ost innovative fields within the chemical 
industry . .Detailed results are to be found in Table 4.1. A comparison with the results of the 
pilot study (see Table 4.1, Column 3) sho~ ex nsive congruence between the results of 
the pilot study and those of the annual repo . The following section constitutes an 
investigation of innovative tendencies by lines business. presented in the order of the 
innovative share of that particular line of business in the total number of innovations. 
Speciality Chemicals The subdivided evaluatio of this line of business shows i:.lte are~ 
of glues/adhesives, preparing agents for textiles and leathers, ~d chemicals used in the 
paper and printing industry to have been particul ly innovative. 
New developments in the field of glues and esives are very often based on further 
developments of polymers. The past few years progress in glues/adhesives technology 
allowed a substitution of traditional mediums · uch as screws and bolts. Technologies 
concerning glues and adhesives are of major ec nomic significance, since they belong to 
the so-called cross section technologies, i. e. they very often form the basis for innovations 
in other Jines of industry, such as the aviation ind stry. 
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Table 4.1 Shares of Product and Process Innovations (in percent) 
Pilot Study Mllin lnvesdcatioo • lnoovadon Couodoc 
Catecory Description or Catecory Share or ProduciiProcess Share io Ecopolidcally Motivated bmovadons 
lonovations 
' 
Innovative Innovative Share of Product Share of Process Share in ecopoli- Share in ecopoli- Share in ecopoli-
Share Share Innovations in Innovations in tically motivated lnno. tically motivated lnno. tically motivated In no. ' 
Innovation Total Innovation Total in Innovation Total in Product Innovation in Process Innovation 
0 Environmental T echnologiu 7.4 2.3 20.0 80.0 93.3 66.1 100.0 
I Basic Organic Chemicals 5.9 3.S 45.7 54.3 39.1 38.1 40.0 
2 Basis Inorganic Chemicals 1.5 o.s 28.6 71.4 28.6 0.0 40.0 ' 
3 Plastics. that do not fit in 31 or 32 o.s 57.1 42.9 14.3 0.0 33._3 
31 Traditional Mass Produced Plastics 4.4 4.0 84.6 15.4 5.8 4.S 12.5 
32 Special Plastics 13.3 11.2 95.9 4.1 8.3 - 1.9 16.7 
Sum Plastics 17.7 15.7 91.7 8.3 7.8 7.0 17.6 
4 Man-made fibres 3.7 3.2 73.8 26.2 7.1 0.0 27.3 
5 Paint. Varnishu 27.4 24.9 94.7 5.3 24.5 22.9 ~2.9 
6 Agrochemicals 6.1 11.8 97.4 2.6 7.2 6.0 50.0 
1 . Maintenance Products 5.9 9.5 96.8 3.2 12.9 11.7 50.0 
&1 Glues and Adhesives 11.1 5.1 100.0 0.0 27.3 27.3 0.0 
82 Petrochemical Additives 1.0 100.0 0.0 30.8 30.8 0.0 
83 Finishing Age!lts for Textile.~ and Leather 4.2 92.6 1.4 16.7 16.0 .25.0 ' 
84 Chemicals for Paper and Printing Ind. 3.4 93.2 6.8· 6.8 7.3 0.0 
85 Chemicals for Photographic Purpose.~ 2.9 97.4 2.6 2.6 2.7 0.0 
86 Chemicals for IT l.l 100.0 0.0 0.0 0.0 0.0 
87 Chemicals for Construction Ind. 1.7 95.5 4.5 0.0 0.0 0.0 
88 Plastic Additives 1.9 92.0 8.0 8.0 8.7 0.0 
: 
89 Miscellaneous 8.2 6.7 92.0 8.0 5.1 5.0 14.3 
Sum Specialities 19.3 27.9 95.0 5.0 11.6 11.6 11.1 I 
_! 
9 New Materials 4.4 0.5 85.7 14.3 0.0 0.0 0.0 
Sum of all Innovations 100 100 90.3 9.7 16.6 u.s 45.1 
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The relatively high share (27 percen_t) of ecopolitically motivated innovations in the field of 
glues and adhesives is mainly due to the introduction of solvent-free gl~es and adhesives, 
such as dispersion binders and adhesives. 
The relatively high share of ecopolitically motivated innovations.conceming additives for 
the petrochemistry results for instance from the substitution of drilling aids based on 
mineral oil by those based on fatty chemicals (biologically decomposable esters) or the 
introduction of environment friendly fuel additives. 
The majority ?f innovations connected with speciality chemicals are product innovations 
(95 percent). This is due to the low production quantities and, at the same time, extremely 
high level of differentiation in the area of speciality chemicals (see product group matrix, 
Figure 2.1). 
Paints and Varnishes Coming second in our quantitative analysis, this line of business 
shows an innovative frequency of 25 percent--with the companies ICI, BASF, Herberts 
GmbH (Hoechst subsidiary) and Akzo representing the market leaders. Analogue to glues 
and adhesives, paints and varnishes have a high share of product innovations (95 percent) 
and ecopolitically motivated innovations (approx. 25 percent). This high share in product 
innovations is, among other reasons, the result of a constant change in fashion concerning 
consumer goods, which leads to new colours having to be introduced into the market with 
great frequency. 
A tendency towards solvent-free varnishes is also noticeable. Especially ·in the automobile 
industry--the primary customer for liquid industrial varnishes--which has increasingly been 
using solvent-free aqueous varnishes in their production (e. g. electrophoretic enamelling). 
Again, polymers played a very important part in the development of these varnishes. A still 
greater potential for development than even these varnishes, however, lies in coating 
powders and multicomponent systems respectively, such as with epoxy-amino systems. 13 
Plastics The investigation shows an innovative share of approximately 16 percent for the 
field of plastics, which places them in the third position. Upon registration of the 
innovations, it was attempted to split the plastics up into two groups. Such a classification, 
however, turned out to present certain problems, since the area of plastics is extremely 
diverse and the information in the annual reports very often does not suffice for a precise 
classification. y e~ there is a distinct difference c~nceming the innovative share between 
the traditional mass produced plastics and the newly developed speciality plastics. The fact 
that the innovative share is more than 10 percent higher for process innovations conforms 
with the statements of the technological life cycle model, according to which the more 
'mature' lines of business produce a higher rate of process innovations. 
13 Cf. Annual Repon Hoechst 199l,.p. 9 
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Very important for the mass produc_tion of plastics was the development of polymerization 
catalyzers. A new class of metal-based catalysers of great chemical variability was 
established with the introduction of metallocenes, i.e. zirconium or hafnium compound~. 
These, among other characteristics, enable the melting point of the developing plastics to 
be fiXed between 100°C and 165°C, and allow their hardness and transparency to be varied. 
In the line of plastics it is not the development of new polymers that is in the fore, but the 
modification of already existing ones.l4 Above all, so-called polymer blends, i. e. polymer 
alloys are being developed and introduced into the market. Composite· materials with a 
polymer matrix are also considered to be innovative areas. They consist of fibre material 
immersed_ in a polymer matrix and, thus, show properties unknown in homogenous 
material. New developments of the fibre industry, such as carbon fibres and aramid fibres 
(aromatic polyamide), are also put to use here. 
Agrochemicals and Fertilizers Their innovative share of 11.8 percent originates almost 
. exclusively from agrochemicals, not from fertilizers. 
Agrochemicals rank amongst the most R&D-intensive lines of business and show 
similarities to the R&D of pharmaceutics. During the course of the investigation, the 
extremely low share of biotechnologically manufactured plant protectives became 
noticeable. Solely, Ciba-Geigy introduced two such products. In research, however, 
biotechnology (gene technology) plays a vital role. This observation coincides with the S-
curve theory. Gene technology is at an early developin_g stage. This leads to the conclusion 
that a rapid growth in biotechnologically manufactUred products is to expected within the 
next few years .. Accordingly, Ciba-Geigy aim at having introduced ten products on a 
biotechnological basis 0 by the year 2000. ICI also describe their biotecllJ:lological 
engagement in plant protection as very intensive and complex, as well as "very long-
term."15 Today's innovations in the field of agrochemicals are still being created by means 
of traditional syntheses, with the focus mainly on a decre~e in concentration requirements, 
an increase in selectivity, a higher environmental acceptability, and a better way of 
distribution on the fields that presents less problems to the farmers (for instance use of non-
powdering granules instead of powder). 
Detergents, Cleaning Materials and Preservatives The high innovative share (9 .5 
percent) in ·this line of business is mainly due to innovations introduced by Henkel. 
Accordingly, more than 50 percent of all innovations produced by Henkel are to be found 
in this category. As far as the relation between product innovations· and process innovations 
is concerned, the conditions are similar to those of the speciality chemicals. 
14 Cf. Chemische Industrie 10/92, p. 29 
15 Cf. Annual Report ICI, 1988. p. 10 
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For detergents, pnonty was giyel! to the development of environment friendly, i. e. 
biologically decomposable, compact detergents. Henkel, for instance, produced phosphate-
free detergents, where the phosphate compounds, which bind the hardening agents of water 
in soluble complexes, are substituted by synthetic sodium-aluminium silicates that belong 
to the zeolites (brand name: Sasil). Furthermore, there is a tendency towards materials on 
the basis of regenerating resources, such as starch and/or fat. The tensides developed by 
Henkel on the basis of alkyl polyglucosides serve as a relevaiu example.16 
Synthetic Fibres This line of fibres accounts for a mere 3.2 percent of all innovations 
and, with the exception of high-tech fibres, ranks amongst the more mature industries. In 
·accordance with the technological life cycle model this is also confmned by the generally 
lower innovative rate and a-relatively high share in process innovations (26.6 percent).· 
The fibres made from polyaramides represent an interesting new development and are 
characterized by extreme stability. Besides these fibres, extremely temperature resistant 
fibres such as fibres from polybenzimidazole or fibres on the basis of polyacrylnitrile were 
specially developed for industrial use·in the aviation and construction industries in order to 
substitute for asbestos.17 In addition, heavy duty fibres are increasingly used in composite 
materials, where their main purpose is an increase of elasticity. 
Basic Organic and Inorganic Chemicals Similar to the production of fibres, basic 
. ' . 
chemicals have -a poor innovative frequency (4 percent), but generate a high share in 
process innovations (54 percent for basic organic chemicals and 71 percent for basic 
inorganic chemicals). Since both these lines of business belong to the more mature 
industries, the results coincide with the relevant statements made in the technological life 
'cycle model. · 
There is also a noticeably high share .in ecopolitically motivated innovations, due to the 
introduction of CFC-substitutes. The 40 percent share in ecopolitically motivated process 
innovations is also very high. Very often these process innovations ·are, in fact, process 
optimizations which aim at a r~duction of arising by-products and waste. Some of them, 
however, are new processes, such as the process Hoechst introduced in order to reduce 
aroinatic amines.ts 
Environmental Technologies · Environmental technologies constitute a relatively young 
area within the chemical industry itself. Their innovative share amounts to 2.3 percent. 
Examples for environmental technologies include the bio-highreactor (Hoechst) or 
recycling plants for plastic waste. 
16 Cf. Annual Repon Henkel, 1990, p. 13 
17 Cf. Hoechst- Neue Wege, p. 83 
18 Cf. Hoecbst- Neue Wege, p.104 
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New Materials The very low stw:e (0.5 percent) of new materials in the investigation at 
hand is due to most of the modem polymer compounds and composite materials belonging 
to the category of special plastics. Ceramic materials, on the other hand, as with special 
glasses, belong to this category. Ceramic materials, above all others, offer a multitude of 
applications, thanks to their hardness as well as their resistance to wear and deformation. 
The innovations in this field aim mainly at a reduction of the typical disadvantages of 
ceramics, such as brittleness as a possible source of fissuring. 
4.1.2 The Innovative Trends oft!Je 1980s and 1990s 
In order to highlight the innovative trends of the investigation period (1984 - 1993), the 
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innOVationS Of the fll'St twO yearS (1984/85) and thOSe Of the last twO yearS (1991/93) Were I 
compared according to lines of business. This was done to draw the attention to possible 
changes in innovative intensity. 
The results are documented in Table 4.~. The strong increase in innovative shares for the 
areas of environmental technologies and products for information technology (specialities) 
is due to the increased economic significance of these industri.es. The extent of ~e changes 
that occurred in the fields of plastics, agrochemicals and preservatives/cleaning materials: 
ho~ever, is. difficult to explain, since the conditions concerning R&D and production \Yere 
not subject to significant changes during these ten years in question. 
Very noticeable is a strong decrease in the number of innovations reported. While 290 
innovations were reported in the years of 1984/85, only 202 were reported for 1992193. On 
the one hand, this can be attributed to the major crisis in which the chemical industry was 
caught up in the beginning of the 1990s. On the other hand, however, this decline can be 
seen as an indicator for the increasing difficulty of the chemical industry to produce 
innovations. The latter would then confrrm the thesis of the chemical L11dust.ry beL11g in the 
so-called phase of maturity. 
4.2 An Analysis of Innovation and Perfonnance .Measures 
I 
. 
The following sections use the extracted data to elucidate the different corporate profiles by 
comparing R&D ·input data· with the relevant R&D outpu! data for the iespeciive 
companies. For each of the companies, we will show which of their lines of business are 
particularly innovative and also identify the lines of business which were able to record an 
especially large turnover growth. The results are then used to explain the differences in 
turnover returns of the individual companies. 
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Table 4.2 Description of Trends: ·comparison of Innovations in 1984/85 
and 1992/93 
Category Description of Ca1egory Number of Shares Number of 
Innovations 1984185 (pet) Innovations 1992193 
0 Eovironmeatal Techoologies 3 LO 12 
1 Basic Orgaaic Olemicals 10 3.4 11 
2 Basis laorgaai~ Olemicals 3 LO 2 
3 Plastics. that do DOt fit io 31 or 32 3 1.0 0 
31 Traditional Mass Produced Plastics 15 5.2 3 
32 Special Plastics 37 12.8 13 
SIUII Pltutia 55 19.0 16 
4 Man-made fibres 11 3.8 10 
5 PainL V amisbes ·14 25.5 35 
6 Agroc:bemicals . 31 10.7 36 
7 MainteDaDce Products 21 7.2 29 
I 
81 Glues aud Adhesives . 15 5.2 8 
82 Peuoc:hemical Additives 5 1.7 3 
83 Fioisbias Ageat.s for Textiles and Leadler 11 3.8 8 
84 Olemicals for Paper aad Priatiag lad. 10 3.4 6 
·35 Olemicals for Photosraphic Purposes 5 L7 0 
86 Olemicals for IT 2 0.7 6 
87 Chemicals for Constructioa lad. 5 L7 4 
88 Pluii" Ad.l.ili VQ 7 2.4 3 
89 M.isa:liaaeous 22 7.6 13 
S11m Specialities 82 28.3 51 
"9 New Materials 0 0.0 0 
SIIDl of allbmovatioas 190 100 lOl 
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Shares 
(pet) 
5.9 
5.4 
LO 
0.0 
L5 
6.4 
7.9 
5.0 
17.3 
17.8 
14.4 
4.0 
1.5 
4.0 
3.0 
0.0 
3.0 
"2.0 
LS 
6:4 
25.2 
0.0 
100 
4.2.1 A Compariso':' of R&D Input ltzdicators 
Comparison of R&D Expense-Intensity Figure 4.1 shows the temporary development 
of R&D expense intensity for the individual companies. It is obvious that almost all 
companies show increasing R&D expense intens.ity. This m~y be due to an increased 
orientation towards the R&D intensive areas of pharmaceutics and speciality chemicals, but 
could also be the result of decreasing R&D productivity. 
The reasons for these differences in R&D expense intensity are mainly to be found in the 
individual corporate proflles. Therefore, differences with respect to innovative strategies 
can only be portrayed with great difficulty by ~eans of this data. Bayer, however, shows a 
vast increase, which is partially due to Bayer planning to increase their pharmaceutical 
share in total turnover by 30 percent by the year 2000. Figure 4.1 id~ntifies four groups of 
companies whose curves ·show similarities. 
. The highest R&D intensities were reached by the two Swiss companies, Sandoz and Ciba-
Geigy. This is mainly due to their strong engagement in the extremely R&D intensive . 
fields of pharmaceutics and agrochemicals. Accordingly, ·in 1993, Sandoz spent 18 percent 
of their pharmaceutical turnover on R&D in the pharmaceutical line. The respective 
European mean value, however, lies at 4.8 percent 
An<~ther group includes Bayer and Hoechst, whose R&D expense intensities were similar 
until the late 1980s. This is due to their similarly structured product ranges as well as · 
comparable corporate sizes; both companies show strong engagement in the fields of 
pharmaceutics, polymers and agriculture. 
Remarkable in this context is the fact that not only their R&D expense intensities· drifted 
apart in the beginning of the 1990s, but also their return on sales (see Figure 4.1). The 
lower R&D expense mtensity shown by Hoechst is mainly due to a large increase in 
turnover as a result of acquisitions, such as Celanese. 
The largest ec.onomic group includes BASF, ICI, Akzo, and Solvay. The R&D expense 
intensities of these companies amount to 3-5 percent These companies are considered to 
be fairly diverse, i. e. their product ranges include raw materials and basic chemicals, as 
well as pharmaceutics. Akzo, for instance, is still very active in the production of fibres, 
while Solvay produces mainly basic chemicals and mass produced plastics--however, they 
are both very much engaged· in the production of phazmaceutics. The vast decrease in R&D 
expense intensity incurred by ICI in 1992 is a result of their having split off their lines of 
pharmaceutics and agriculture. 
The lowest R&D intensity, ·approximately 3 percent, was shown by Henkel. Most likely. 
their mu1titude of consumer products, such as Persil, requires little R&D, yet ·contributes 
greatly to their turnover. 
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Figure 4.1 R&D Intensities for Large Chemical Firms, 
1984-1993 
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Table 4.3 R&D Shares of Individual Lines of Business 
Company R&D Share Bigger R&D Share and Sales R&D Share Smaller 
than Sales Share Share more or less than Sales Share 
I EQual 
:~;layer Pharmaceutics Polymers Industrial Chemicals 
AIUiculrilre A2fa-Gevaert 
BASF Agriculture Chemicals Gas and Oil 
(as of 1991) Consumer Goods Colorants/ Plastics/Fibres 
Refininl! Products 
Hoechst Pharmaceutics Polymers 
(as of 1986) Agriculture . Technics 
Chemicals/Paints 
Fibres/Foils 
ICI no data supplied 
Ciba-Geigy Pharmaceutics Agriculture Industry 
(as of 1991) 
Sandoz Pharmaceutics Seeds 
A2rochemistrv 
Akzo no data available 
Henkel no data available 
Solvay no data available 
Table 4.3 shows the different R&D expense intensities mentioned above. According to the 
data extracted from the annual reports the R&D shares were estimated against the turnover 
shares for the respective lines of business and then split into three categories. The R&D 
share refers to the share of the respective. line of business in the ·R&D budget of the 
individual company. Please note that the defmitions of these lines were a.dapted from the 
individual companies and are therefore not uniform. The share in turnover refers to the 
share of the respective line of business in the turnover of the individual company. 
An R&D share of a certain line of business exceeding the respective turnover share 
indicates that the line of business in question is an ~&D intensive one. R&D-intensive 
fields include pharmaceutics and agrochemicals, while lines such as mass produced plastics 
and fibres belong to the lines with a lesser R&D intensity. 
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Applied to the S-curve model, ~e results from Table 4.3 show a bigger innovative 
potential for phannaceutics and agrochemicals, since companies with knowledge of the S-
curve tend to invest more into lines of business with a high innovative potential. 
Comparison of R&D Personnel Intensity The evaluation of R&D personnel intensity is 
subject to certain limitations. Thus, the high personnel intensity of BASF is largely due to 
their production being less p~rsonnel intensive than the production of Bayer or Hoechst. 
This means that the three companies differ not so much in the number of R&D personnel, 
but in their total number of employees, as is also confirmed by the low share of salaries and 
wages in the turnover (see also Table 4.4). 
The data pertaining to Henkel and Solvay, however, can only be evaluated in a 
contradictory manner. Solvay shows an extremely low R&D personnel intensity, although 
their not very personnel intensive production should indicate a high R&D personnel 
intensity, further, their R&D expense intensity conforms to the mean value for that 
particular line of business. The reasons could possibly be found in their extremely capital-
intensive, yet bare~y personnel-intensive R&D. 
It is also noticeable that Henkel shows a relatively high R&D personnel intensity, as 
opposed to their very low R&D expense ,intensity. The low R&D expense intensity (2.9 
percent) of this company s~ms to indicate that Henkel's R&D is not very capital-intensive. 
Perhaps, the above mentioned discrepancies may be attributed, however, to the diverging 
classification criteria appertaining to R&D personnel used by the individual companies. 
Table 4.4 R&D Personnel-Intensity (10-year averages) 
Company R&D Personnel-Intensity Compati,Y Share of Salades 1 
(%) and Wages in Turnover(%) 
Bayer 7.6 24.4 
BASF 9.1 18.0 
Hoechst 8.4 23.5 
ICI 6.8 16.2 
Ciba-Geigy no data available 
Sandoz no data available 
Akzo 9.1 22.8 
Henkel 7.3 17.6 
Solvay 5.5 18.5 
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4.2.2 A Comparison of R&D Outputs 
Table 4.5 shows the three most innovative lines of business for the individual companies, 
with the numbers in parentheses indicating their innovative core activities within the area 
of plastics and speciality chemicals. The allocation is based on the classification system 
established in the study at hand, not on the categorization of the individual companies. See 
Table 4.6 for a detailed evaluation. 
The order of precedence elucidates once more the different corporate proflles. All in all, the 
high portion of plastics, speciality chemicals and paints/varnishes is noticeable. The fact 
that agrochemicals, in spite of their ranking amongst the most R&D intensive fields, only 
come in third, is partially due to their lower share in turnover. As a result of inconsistent 
line defmitions (turnover shares in accordance with the companies' classifications, and 
innovative shares in accordance with the classification system established in the present 
study), an actual weighing of innovative shares against their turnover shares was not 
feasible. 
Table 4.5 Ranking of Innovative Core Activities by Individual Companies 
Company Position 1 Position 2 Position 3 
Ba_y_er Speciality Chemicals (81) PaintsNarnishes Plastics (32) 
BASF PaintsNarnishes Plastics (31) Speciality Chemicals 
Hoechst Plastics (32) PaintsN arnishes Agrochemicals 
Speciality Chemicals 
ICI Speciality Chemicals PaintsN arnishes Agrochemicals · 
Ciba-Geigy PaintsNarnishes S_Qeciality Chemicals Agrochemicals 
. 
Sandoz Speciality Chemicals (83) PaintsN arnisbes Agrochemicals 
' 
Akzo PaintsN arnisbes Speciality Chemicals Agrochemicals 
Henkel Maintenance Speciality Chemical~ (81) insignificant 
-Solvay Plastics (32) Speciality Chemicals Basic Organic Chemicals 
The innevative core activities of the individual companies also explain the different R&D 
expense intensities as shown in Figure 4.1. BASF, for instance, has their innovative core 
activities in paints/varnishes, as well as in mass produced plastics. The R&D expense 
27 
' . 
i 
1\.) 
():) 
Table 4:6 Innovative Shares According to Categories and Corporate Evaluation (in percent) 
Category ' Description of Category Bayer BASF Hoechst ICI Ciba- Sandoz Akzo 
Geigy 
0 Environmental Technologies 1.9 2.0 7.4 5.5 0.0 1.3 0.0 
I Basic Organic Chemicals 3.7 2.8 3.7 6.6 0.0 0.0 8.5 
2 Basis Inorganic Chemicals 0.0 0.0 3.7 2.2 0.0 0.0 0.7 
3 Plastics. that do not fit in 31 or 32 1.1 0.4 0.0 1.1 0.6 0.0 0.7 
31 Traditional Mass Produced Plastics 0.7 14.2 4.9 0.0 0.0 0.0 0.0 
32 Special Plastics 16.7 11.9 19.8 11.0 14.0 1.3 0.1 
Sum Plastics 18.6 26.5 24.7 12.1 14.6 1.3 1.3 
4 Man-made fibres 3.3 2.4 9.9 2.2 0.0 1.3 10.5 
5 Paint. Varnishes ,l3.8 34.4 16.0 24.2 29.9 27.6 41.2 
6 Agrochemicals 16.4 4.7 14.8 16.5 24.4 21.1 15.7 
7 Maintenance Products 3.3 4.7 2.5 3.3 2.4 3.9 3.3 
' 
' 
81 Glues and Adhesives 3.7 2.0 0.0 3.3 5.5 1.3 0.7 
82 Petrochemical Additives 0.0 2.8 1.2 1.1 0.0 0.0 0.0 
83 Finishing Agents for Textiles and Lealher 4.8 5.S 0.0 1.1 4.9 18.4 0.0 
84 Chemicals for Paper and Printing Ind. 3.7 4.7 7.4 2.2 0.0 9.2 2.6 
85 Chemicals for Photographic Purposes 13.0 0.0 0.0 0.0 1.8 0.0 0.0 
86 Chemicals for IT 2.2 2.4 1.2 1.1 0.0 0.0 0.0 
87 Chemicals for Construction Ind. 1.1 0.0 0.0 2.2 0.0 9.2 0.7 
88 Plastic Additives 0.0 2.0 0.0 3.3 6.1 3.9 2.0 
89 Miscellaneous 5.6 3.2 6.2 12.1 10.4 1.3 II. I 
Sum Specialities J-1.2 22.5 16.0 26.4 28.7 43.4 17.0 
9 N~:w Materials 0.7 0.0 1.2 1.1 0.0 0.0 2.0 
Sum or uJJ ltmovatlons 269 253 81 91 164 76 153 
Henkel Solvay Total 
3.1 5.8 2.3 
1.3 9.6 3.5 
0.0 1.9 0.5 
0.0 0.0 0.5 
0.0 19.2 4.0 
0.6 34.6 11.2 
0.6 53.8 IS.1 
0.0 0.0 3.2 
2.5 0.0 24.9 
0.0 11.5 11.8 
' 
53.1 1.9 9.5 
23.1 0.0 5.1 
2.5 0.0 1.0 
2.5. 0.0 4.2 
1.9 0.0 3.4 
0.0 0.0 2.9 
0.0 0.0 1.1 
3.8 5.8 1.7 
0.6 0.0 .., 
5.0 9.6 6.7 
39.4 15.4 21.9 
0.0 0.0 0.5 
160 52 1299 
-- ------
intensity for paints/varnishes at BA~F amounted to merely 2.68 percentl9 in 1988, a figure 
much lower than the company's total R&D expense intensity of 4.1 percent. 
Another· very interesting figure is Henkel's share of preservatives and cleaning agents of 
more than 50 percent. This line of business seems to require only very low R&D expense 
intensity, a theory which would at least explain Henkel's low R&D expense intensity. As 
for Sandoz, their high share of preparing agents for textiles and leathers, which exceeds 
even the innovative shares of paints/varnishes and agrochemicals, calls for attention. 
The intended evaluation of companies with a view to innovative strength by way of their 
number of reported innovations could not be carried out, since during the course of the 
investigation the companies' inclination to actually report their innovations turned out to 
vary considerably. Bayer, for instance, reported 269 innovations during the investigation 
period of 1984-1993, whil~ Hoechst with their similar range of products reported a mere 81 
initovations over the same period of time. Another argument against an evaluation of the 
companies' ability to innovate is the fact that their product ranges differ considerably, while 
this study was not in a position to consider anything but their chemical fields: Accordingly, 
the innovative shares shown in Table 4.6 refer only ·to their chemical activities in 
accordance with the classification defmition underlying the study at hand. 
4.2.3 Growth in the Individual Lines of Business 
Table 4.7 splits up the individual ~es of business into the groups of growth, relative 
consistency and decline, according to the· development of their turnover during the period 
of 1984 -.1993. In this case, the companies' defmitions of the individual lines of business 
were adapted by the study at hand. 
Growth in pharmaceutics and/or consumer-related business lines such as cosmetics 
(Henkel) or consumer goods (BASF) is of major strategic importance for almost all the 
companies. The area of paints and varnishes is also expanding, at least as far as Akzo and 
ICI are concerned: The lines of plastics, fibres and agriculture, on the other hand, are on the 
decline. The companies under investigation also suffered a turnover decrease in the areas of 
raw materials/~nergy (BASF) and petrochemicals (ICI), respectively. Also worth 
mentioning is the consistency s~own by Sandoz with respect to their turnover shares. 
The conformance between R&D expense intensity and turnover growth for the individual 
lines of business is remarkable.· Therefore, a positive relation between R&D expense 
intensity and turnover growth can safely be said to have been established, except where 
agriculture is concerned. Although agriculture ranks amongst the R&D intensive lines of 
business, it does not belong to the lines whose turnover is expanding. This is partially due 
to the declining turnover rates in fertilizers. Innovations, on the other hand, are to be found 
l9 Cf. Robe, p. 20 
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in the area of agrochemicals, i. e. i~ insecticides, herbicides, etc., while the hig~ degree of 
R&D intensity can partially be attributed to the strict environmental and application 
regulations. 
Table 4.7 GroWth Trends by Individual Lines of Business 
Company Growing Fairly Constant Declining 
Bayer Pharmaceutics Polymers 
Organics 
Industrial Chemicals 
Agriculture 
Aszfa-Gevaert 
BASF Consumer Goods Colorants Chemicals 
Plastics Refining Products Agriculrure 
Raw Materials/Energy 
Hoechst Pharmaceutics Agriculture Fibres 
Technics Polvmers 
ICI Pharmaceutics Chemicals Petrochemistry and 
PaintsNarnishes Plastics 
Ciba-Geigy Pharmaceutics Colorants . Agriculrure 
Chemicals Polymers 
Pigments 
Mettler 
Sandoz Chemicals 
Agriculture , 
. Pbannaceutics 
Nutrition 
Seeds 
Akzo Pharmaceutics Fibres 
PaintsNarnishes 
Chemicals 
Henkel Cosmetics Detergents/ Chemicals 
Cleaning Agents 
Glues/Adhesives 
Technical Brands 
Hygiene and Metallo-
ChemistrY 
Solvay Pharmaceutics Alkalines 
Peroxides 
Plastics and 
Plastic Processine: 
According ·to Table 4.8 growth rates of. the .various companies differed greatly. These 
differences are largely due to acquisitions. Since there is no way to identify exactly the 
individual shares of said growth, i. e. the share based on i~novations and the share based on 
acquisitions, company growth is not included in the present study. 
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Table 4.8' Mean Accounting Ratios 
R&D R&D to R&D- rei. R&D Salary Retumon Retumon Return on Retumon Increase 
Company Intensity Balance Personnel Personnel Share Sales Equity Total Operating Turnover 
(RD/Sales) Sheet Intensity Intensity of Turnover Assets Profit 
Total 
Bayer 6.2 7.3 7.6 1.2 24.4 3.9 11.3 7.1 10.4 0.87 
BASF 4.0 S.3 9.1 2.3 18.0 2.5 8.6 4.8 B.S. 0.78 
Hoechst S.1 7.6 8.4 I.S 23.5 3.S 13.0 7.3 9.6 2.54 
Ia 4.1 4.S 6.8 1.9 16.2 S.2 9.0 8.4 9.8 2.23 
Ciba-G. 1(}.0 7.4 30.3 7.0 8.6 6.8 4.S 2.52 
Sandoz 9.4 8.6 20.8 7.8 13.0 8.9 s.s 7.38 
Akzo 4.8 6.1 9.1 1.9 22.8 4.S 16.4 7.9 10.3 -0.31 
Henkel 2.9 4.0 7.3 2.4 17.6 2.9 9.9 7.0 7.9 4.13 
, Solvay 4.4 4.6 s.s 1.3 18.5 4.2 13.4 6.1 10.0 0.86 
Note: For Ciba-Geigy salary shares of turnover include social expenditures 
" ----~-- - --·- ·-~- -·~- ~ ~" ~- --- _ _,..,_ - - -- ·-~- --- .. ,-.,, ;>- .........,.__,_, --.- • ~ .. - - ~---· ~ --~· ~-~ --
Increase Increase Increase Increase I 
R&D- · Balance Employ- R&D-
Expenses Sheet ment Employees I 
Total 
5.13 2.58 -1.46 -0.64 I 
3.17 4.70 -2.39 -0.62 
5.81 4.88 -0.77 0.46 
9.08 3.49 0.12 
4.27 3.69 0.76 
10.SS . 10.11 3.48 I 
4.86 3.10 -1.02 2.14 I 
6.SS 6.SS 2.30 2.02 
5.21 3.79 -0.15 ' 
---
-·--~ 
--
~-
• 
The data found in Table 4.7 is directly related to the product life cycle model, since it is in 
said product life-cycle model that the stages of maturity are identified by way of turnover 
growth. Accordingly, those lines of business that show a growing turnover--pharmaceutics, 
paints and varnishes, etc.--are placed in an earlier stage of maturity than the areas of fibres 
or chemicals. 
~.2.4 Corporate Success and Profitability in the Individual Lines of 
Business 
The development of the return on sales as shown in Figure 4.2 reflects the cyclical trends 
which have occurred. The different rates of return on turnover for the individual companies 
largely depend on the respective corporate profiles. See Table 4.9, Column 2 for the most 
profitable fields. Accordingly, those companies are the most successful whos~ turnover 
originates mainly from those lines. The companies with profitable pharmaceutics lines 
were the most successful ones. Furthennore, it is noticeable that: 
• the two Swiss companies, Ciba-Geigy and Sandoz, were able to actua)ly achieve a 
turnover growth at a time when most companies were suffering a decline in turnover 
returns. This is probably due to their ·strong orientation towards pharmaceutics and 
speciality chemicals. Besides, Sandoz is strongly represented in markets for 
consumer goods, such as nutrition. 
• some companies, such· as Bayer and Henkel, seem to be less dependent on market 
swings than others such as Solvay, ICI or BASF. Basic chemicals and plastics are 
considered especially cyclical, while othe~ fields (such as phannaceutics, part of the 
specialit)' chemicals, cosmetics, and varnishes) are rather resistant to cyclical swings. 
Table 4.9 classifies the business lines of the various companies according to their 
profitability. A share in operating result exceeding the share in turnover of a particular field 
reflects a contribution towards the corporate success for this particular line of business 
which is above average. More or less balanced shares reflect an approximate equivalence 
of turnover return (where return ·on turnover is defined as the quotient from operating result 
and tUrnover) of .this particular line of business and the total return on turnover of "the 
company. 
Pharmaceutics are· by far the most profitable lines of business. Over and above all other 
fields, it is noticeable that those lines are particularly successful where the individual 
companies hold a strong market position--such as ICI for explosives, Solvay for_.alkalines 
and per~xides, and BASF for part of their fmishing products (varnishes). However, most of 
these results refer t<;> the period of 1988 - 1993, a period which coincided with the grave 
recession that affected the chemical industry, so that distortions may have to be accepted. 
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Figure 4.2 Return on Sales for Large Chemical Firms, 1984-1993 
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Plastics, especially, are much more profitable in more favorable cyclical periods than is 
reflected in Table 4.9. Due to these inaccuracies and due to the assumed dependency on the 
respective market position, no conclusions can be drawn with respect to the product life 
cycle model . . 
Table 4.~ Profitability a,nd Sales S~are of the Individual Lines of Business 
Company Share in Operating Share in Operating Share in Operating 
Result Bigger than Result and Sales Share Result Smaller than 
Sales Share more or less Equal Sales Share 
Bayer Pharmaceutics Organics Polymers 
{as of 1988) Industrial Chemicals Agfa-Gevaert 
Agriculture 
BASF . Chemicals Raw Materials/Energy Plastics 
{as of 1990) Colorants Agriculrure 
F'mishin2 Products Consumer Goods 
Hoechst Pharmaceutics Agriculrure Polymers 
{as of 1988) Chemicals and Paints Technics 
FibresJFoils 
ICI Pharmaceutics Petrochemistry/Plastics Agriculrure 
{Various feriods Exp~osives Varnishes and Paints fibres 
of Time) Chemicals 
Ciba-Geigy Pharmaceutics Agriculture Industry 
(as of 1988) 
Sandoz no data available 
Akzo Pharmaceutics Chemicals Fibres 
PaintsNarnishes 
Henkel no data available 
Solvay Pharmaceutics Plastic Processing Plastics 
Alkalines 
Peroxides 
4.3 Limitations and Conclusion 
The main problem is the _complete lack of obligatory defmitions concerning the 
classification of expenses as R&D-related. The so-called "Frascati-manual," published by 
the OECD merely documents relevant recommendations.2° Since research oriented 
chemical companies are considered dynamic and expansive, the companies are interested in 
reporting maximum R&D expense rates. According to Amecke21, many chemical 
companies declare R&D expenses which are of an exclusively tlefensive nature, such as 
20 Cf.· Scbwitalla, p. 101, and Kuhn, p. 107 
21 Cf. Ainecke, p. 31 
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toxicological examinations of already existing products, or advice on applicational problem 
solving, which should, in fact, be considered part of the sales activities. 
Since, as a rule, R&D is extremely personnel-intensive, a large part of R&D expenses is 
attributed to personnel costs. However, the classification of R&D related personnel can be 
carried out according to varying criteria arid country-specific :variations in pay-scales can 
further contort the figures concerning R&D expense-intensities. 
Despite the uncertainties described above, our analysis showed mainly plausible figures 
and tendencies. Schwitalla22 and Graumann,23 who both investigated the annual reports of 
German companies, came to the conclusion that annual reports comprise R&D data, in 
particular on R&D expenses,' of a surprisingly high quality. 
Most of our problems were encountered in co~nection with the innovation counting and are 
due to the differing degrees of available information in the various annual reports. It was 
not possible to evaluate the companies' innovative readiness due to the varying tendencies 
of the companies to actually report their respective innovations. Another problem is the 
often rather imprecise information on ·in~ovations, which very often shows near 
advertisement character. In accordan~e with this data it was impossible to evaluate the 
quality of the reported innovations, i. e. there was no way of differentiating between 
incremental product changes and totally new products. Imprecise data also made the 
c~assification of categories extremely difficult Especially in the area of plastics, where the 
classification according to chemical criteria is also not very clear-cut--it was not possible to 
differentiate between mass produced plastics or further deveiopments based on them and/or 
special plastics. 
The innovation counting was further hampered by whole new product lines being 
introduced instead of an exact numbers of innovations. Whenever details were given as to 
the number of products within a certain line of products, the respective number of 
innovations was considered. Therefore, repetitions of brand names may be found in the. 
evaluation, since often innovations were, in fact, improvements with no change of name, or 
else individual products out of a line of products with only one brand name. 
Due to the unclear information concerning the economic use of catalyzers (whether as an 
individual product or as part of a process improvement), catalyzers were always c~unted as 
process innovations unless they were explicitly marked as products. · 
Despite the necessary assumptions in the innovation counting and the uncertainties 
concerning the annual reports the results achieved are plausible and enable a reasonable 
22 Cf. Scliwitalla, p. 272 
23 Cf. Graumann, pp. 185 
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description of the innovative trends prevailing in the chemical industry. This is also 
~onfmned by the relatively great conformity with the previously created pilot ·.study 
(innovation counting on the basis of information taken from the magazine "Europa 
Chemie"). 
Most noticeable is the interdependence of R&D expense intensity and return on turnover. 
This means that companies with a high investment in R&D are, in fact, the most successful 
ones. The evaluation by lines of business, however, shows the level of R&D expense 
intensity as extremely dependent on the respective corporate profile, i.e., it demonstrates 
which lines of business the company in question engages in. Thus, the interdependence 
mostly concerns corporate proflle, R&D expense intensity and return on ·turnover. The 
'evaluation by lines of business also shows the R&D intensive lines to be those lines which 
produce the best turnover growth. · 
These connections serve to confmn 'the statements of the S-curves and the product life 
cycle modeL Thus, it was shown that the companies tend to spend particularly large sums 
in business lines with a high potential for growth and profit (such as pharmaceutics). As. far 
as biotechnology is concerned, the time lag between the stages of maturity of the S-curve 
model and those of_the product life cycle model was proved as-well. 
·The lines identified as more mature lines due· to lower R&D expense intensity were also 
classified as more mature lines when applied to the technological life cycle model. This 
means that, when- compared with other lines of business, they show a lower innovative 
frequency and at the same time a higher share of process innovations (e.g. fibres or basic 
chemicals). 
The evaluation of the innovation counting elucidates the companies' tendency towards 
speciality chemicals and/or pairits and varnishes, which actually resemble the specialities in 
many aspects . 
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S Innovation Trends II: An Analysis of Corporate Strategies 
I 
~ 
. 5.1 Corporate Strategies and Innovation: Analysis of Annual Reports and 
First Insights from the CIS Data Base 
The following section introduces several basic innovation and corporate strategies, which 
are of major importance to the fu~ development of the European chemical industry. It 
describes the underlying conditions cwrendy determining corporate strate_gies. In addition, 
it shows the companies' reactions on the developments identified in the previous section. In 
older to relate our analysis of the nine large European chemical fmns to the CIS data base 
we will test some of the propositions developed are already in this section. That is, unless 
other sources are explicitly stated, the relevant data originates from the respective annual 
reports and from the CIS data base. 
5 • .1.1 Changed Conditions in Europe 
The major crisis which gripped the European chemical industry in the early 1990s was a 
structural on~. The companies' reactions to this crisis consisted in structural adjustments 
and rationalisation measures, which brought forth considerable manpower reductions. The 
vast extent of these manpower reductions is elucidated in Figure 5.1. In early 1995, the 
. -
,total number of personnel employed in the European chemical industry _is approximately 
255,000 less than in 1991-a decrease of 14 percent.24 
· The reason for these structural problems, some of which still exist today, are, above all, to 
be found in the considerable cost disadvantages in connection with mass products, such as 
base materials, plastics, fertilizers and fibres compared with producers outside Europe. 
These cost disadvantages result mainly from higher. costs for raw materials, labor and. 
environmental protection. High labor costs as a reason for competitive disadvantage 
prevalent in Western Europe are shown in Table 5.1, with a broad vanation of costs even 
within Europe itself. In addition, there has been a shift in the production of chemicals 
towards the locations. of major customers. The exodus of the textile industry2S into the Far 
East is the result of an increas~ production of synthetic fibres in that area. A similar 
danger prevails in R&D-intensive fields, such as the production of highest-grade chemicals 
for microelectronics. 
The Middle East countries in particular, but also Mexico, have at their disposal -a supply of 
raw materials for a large number of base chemicals and mass produced plastics at keen 
prices that have no competition whatsoever. These countries aim to produce methane and 
24 Cf. Economist. p. 69 
2S Cf. Amedee. p. 37 
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Figure 5.1 Employment for Large Chemical Firms~ 1984-1993 
' 200000 -r------- -~- ---#--·~· --· ··--------------------------· -----
180000 t t . -:-
160000 
140000 
/''' -····-··· --·•··········· #•····--· 
120000 J. /------------
' ")E . M" 
~ g 100000 
~ . . . ~ ! 
80000 - -liE - - - - •- - - - - :t Q. • --· liE 
-·-----·----·-----+-----+-----+--.:...--:--:--+--_ -~-
------ - . . ' 
----- • 0 • -----------
-1--·---r -~--... --=-=-~·:-:~~-:~:~J 
20000 
0~----+-----~-----+--
1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 
Year 
• Bayer· 
········•····-·-- BASF 
• Hoechst 
M ICI 
liE Ciba-Geigy 1 
• Sandoz I 
Akzo 
Henkel 
..,.. ---~olvay I 
ethane based petrochemicals, normally by-products in the production of crude oil that need 
to be burnt off, in large plants at low operating costs and thus achieve significant 
competitive advantages.26 Accordingly, the world market share of. these Middle East 
countries for ethylene glycols is expected to rise from 12 percent in 1991 to 20 percent in 
2000. Western Europe will tum more and more into a net importer for petrochemicals and 
standard plastics, a development which, in the long run, will. become evident for high-grade 
plastics as well.2' 
Table 5.1 Chemical Labour Costs pe.,- Man-Hour 
Country 1994 (in DM) %of 1993 
West Germany 62.71 +3.2 
Belgium 58.15 +2.8 
Japan 55.87 . -3.0 
Netherlands 55.17 +0.5 
France 48.47 +1.5 
Denmark 45.85 +4.2 
Italy 36.51 +0.3 
Luxembourg 35.40 +2.9 
USA 34.91 +0.9 
Great Britain 34.15 0 
Ireland 34.04 +4.2 
Spain 29.87 -2.0 
Greece 18.57 +5.7 
Portugal 17.82 +17.5 
.. (uncertain) 
Source: Frankfurter Allgemeine Zeitung dtd. 06 October 1995, p. 24 
The 1980s were_ also characterized by high expenses for the compliance ~ith 
environmental standards. Accordingly, the environmental costs for the German chemical 
companies amounted to 6.4 billion DM or 4 percent of their 1990 turnover, which 
represents a 25 percent increase in comparison with the previous year. 28 These costs, 
however, have successfully been cut in half in the meantime, so that in 1994 Bayer invested 
26 Cf. Riemann, p. 18 
27 Cf. Fond der Chemischen Industrie, p .. 14 
28 Cf. Riggert, p. 9 
39 
. ' 
' 
I 
' 
I 
., 
I • 
' . 
a mere 330 million OM--approximately half of their environment protection investment of 
1990.29 
As a result of above developments, companies are increasingly backing out of unprofitable 
production. This, in tum, presents a serious danger to historically interrelated production, 
which guarantees maximum benefit foom utilized raw material and energy. As a result, 
interrelated structures will collapse as more and more members of these complex 
production links become unprofitable and thus lose what little cost advantages they have 
left3° 
Under these· circumstances, a concentration on more refmed, more R&D-intensive products 
becomes even more important A current st~dy carried out by the British Chemical 
Association31 identifies those areas of R&D which will be of major importance in the 
future. In consideration of all chemical fields, the following list of priorities concerning 
promising technologies was established: 
1. Biotechnology and Catalysis; 
2. Materials; \ 
3. Process Technology; 
4. Separation Processes, Analytics and Moulding. 
Japanese and American companies engaged in the R&D of these promising fields receive 
government promotion for innovation (such as tax rebates and allowances for R&D in 
addition to a purposeful governmental purchasing policy). On the other hand, some West 
European countries, particularly Germany, rather obstruct the progress of research through 
the introduction of rigid laws and regulations. for instance in the field of gene technology. 
The Institute for Applied Innovative Research of Bochum, Germany, investigated the 
restraining effect on the innovative process caused by the 1982 chemical law. The study 
came to the conclusion that the present chemical law with its prevailing testing methods 
and application procedures entails vast competitive disadvantages for German companies . 
. At the same time, it impedes the access to the market for medium-sized and small 
companies. 32 The poor social acceptance of chemical research reflected in such laws has 
29 Cf. Frankfurter Allgemeine Zeitung dtd. 12 July 1995, p. 22 
30 Cf. Forltl der Chemischen Industrie, p. 13 
31 Cf. Chemical Industries Association, P.· 72ff 
32 Cf. Chemische Industrie 4/94, p. 16 
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lead to research in the more promising fields increasingly being shifted abroad, for instance 
to the USA and Japan. 
As a result of two plebiscites, the Swiss chemical companies were at one point in danger of · • 
having to give up altogether a vital part ~of their pharmaceutical research, namely animal 
experiments. Had these plebiscites been successful, a strong shifting of research activities 
abroad would surely have occurred. 
5.1.2 The Main Strate"gies Driving Innovation: Cost Leadership and 
. Specialization 
We considered strategy so far from the point of view of nine large European chemical 
fmns. For a statistical analysis, we will use the CIS data base to explore the European 
. perspective more systematically. However, due the lack of data for some countries and 
. segments of the industry the analysis focuses on the so-called 6-country sample which 
includes Belgium, Gennany, Ireland, Italy, Luxembourg, the Netherland, Norway, and the 
United Kingdom. 
Two broad lines of strategy research are of interest with-respect to the chemical industry. 
The frrst group following up the pioneering work of Alfred Chandler (1962), who 
undertook a series of studies into the evolution of the strategy and structure of large-scale 
industrial companies in the U.S., the U.K., France, Gennany, and Italy. These studies found 
a trend toward increased diversification, .primarily into areas of related activity, and that the 
fmns had adopted a form of divisional organization structure. This structure dominates 
t()(iay, at least with the large fmns of the chemical industry. 
The.second seemingly important distinction of strategies was developed by Michael Porter 
(1985). In a simplified version of that work one can distingiush three types of strategies, 
that is, a strategy of cost leadership, a strategy of product differentiation, and a strategy of 
being stuck in the middle. The analysis of the annual reports has shown that the distinction 
of cost leadership versus product differention (or specialization, as we will call this 
strategy) is a relevant one for the fmns of the chemical industry. Thereforet and because of 
the patterns of the fmn size distribution in various segments of the industry we will use the 
concept of cost leadership and specialization strategy for the following analysis. 
The Table 5.2 shows that the large fmns33 are located in the industry segments basic 
chemicals (24.1), soap and detergents (24.5), and man-made fibres (24.7).34 The share of 
fmns in these segments is in the highest turnover groups (no. 4 and 5) 15 percent and more. 
33 Size is measured as annual turnover in thousand ECU. The size distribution then is based on five groups of 
turnover. 
34 The pharmaceutical industry is included for the purpose of comparison, but will not be further discussed in 
the context of the tables. 
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Table 5.2 Distribution of Firms by 1992 Turnover Size Groups and Segments of 
Industry (in percent, 8-country sample) 
Size Group by Turnover (thousand ECU) 
I 2 3 4 5 
Industry Segment (NACE) (0-499) (500- (10,000- (100,000- (500,000+) 
9,999) 99,999) 499,999) 
Basic Chemicals (24.1) 1.0 34.0 45.8. 13.3 6.0 
Agrocheniicals (24.2) 2.8 41.7 44.4 8.3 2.8 
Paints; Varnishes (24.3) 1.0 53.8 39.4 5.3 0:5 
Phannaceuticals (24.4.) . 0.8 30.6 47.5 18.0 3.2 
Soap and Detergents (24.5) 15 46.1 36.8 13.2 2.5 
Other Chemical Products (24.6) 1.7 51.0 41.9 3.3 2.2 
Man-Made Fibres (24.7) 0 39.6 45.3 15.1 0 
Column 19 677 709 181 51 
Total 1.2. 41.4 ·43.3 11.1 3.1 
Note: The 8-country sample includes Belgium, G~rmany, Ireland, Italy, Luxembourg, the 
Netherlands, Norway, and the United Kingdom. 
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Total 
Number of 
Finns 
400 
36 
208 
373 
204 
363 
53 
1637 
100.0 
•. 
Paints and varnishes (24.3) and other chemical products (24.6) have SO percent and more 
fmns in the lower size groups 1 and 2. Agrochemicals is between these two groups with a 
value of 44.S percent 
The results are reasonable because the production of basic chemicals requires considerable 
amounts of capital which usually can be afforded only by lage fmns. The manufacture of 
paints and varnishes is, on the other hand, often feasible as speciality production, that is, a 
lower volume can be marketed profitable by providing a variety of products. This is an 
environment where cost le,adership strategies based on capital intensity are not a neccessary 
condition for the survival of small and medium sized firms since the domain for cost 
leadership strategies looks different 
Cost Leadership The strategy of cost leadership is mainly pursued in areas where the 
price is the decisive ·competitive feature. According to the Technological Life Cycle Model 
this is often the case with products where product 'innovations accordingly play a less 
importailt role~ This applies to mass produced plastics and base chemicals, but is also 
partially true for certain parts of the specialized chemistry.3S 
For the achievement of cost advantages, the availability of low-priced raw material supplies 
as well as the attainment of a high market share for better use of the sometimes immense 
scale economies, are of vital importance. In this context, stronger concentration efforts 
were made by the European chemical industry during the past few years, which were also 
connected with a strategic tendency for concentration on the individual· companies' core 
areas and/or a tendency to form strategic alliances. 
Thus, BASF acquired ICfs European polypropylene branch and, in tum, sold their 
plexiglass line to ICL As far as· synthetic fibres are concerned, BASF .is concentrating on 
the production of nylon-6, a purpose for which ~ey formed a joint venture with Allied 
Signal. With polyester fibres, on the other hand, BASF is following a policy of divestment 
and are putting their focus on the production_ of polyurethane. In. order to secure a relatively 
favorable raw material supply, the company spent 1.3 billion DM to build a new steam 
cracker in Antwerp. 
The CIS measures the pursuit of the cost leadership strategy in question S as a goal of 
innovative activities. This is plausible because goals ate part of the corporate strategy and 
the goal lowering production cost is at the core of a cost leadership strategy. More than· SO 
percent of the firms in the. sample persue the goals reducing the share· of wage costs and 
reducing materials consumption. 36 
35 Cf. Chemische Industrie 8/89, p. 28 
361bese are the points 4 and 5, respectively ,very significant" and ,,crucial" in the Likert scale measurement 
of question 5. More than 50 percent of the f111DS have made this evaluation- with the exception of France and 
Ireland for wages and tbe exception of France for ma~rials. 
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Reducing energy consumption· is paticulmly important for the production of basic · 
chemicals since a significant share of their cost is due to energy consumption. For 16 
percent of these fmns reducing energy consumption is crucial. The situation is different for 
the producers· of agrochemicals or pain.ts and varnishes. For the former only 4 percent 
regard reducing the consumption· of energy as crucial and for the latter 8 percent of the 
fmns. Thus, a strategy of cost leadership by reducing· energy consumption is first of all 
pursued in the field of basic chemicals. 
Specialization The strategy of specialization constitutes an attempt on the part of the 
chemical companies to escape from the price competition dominating the market for mass 
products. For the chemical industry, specialization means mainly an orientation towards 
specialities --barring above mentioned exceptions--, i. e., a concentration on the companies' 
part on certain niass products with the aim of securing cost advantages. The specialities are 
characterized by a great product diversity, such as certain "tailor-made" polymers (Akzo) or 
master batches made· to customers specifications for the use of pigments and additives with 
plastics and synthetic fibres (Sandoz). As a rule, these products are highly refined ones and 
usually g~tee a higher profit margin. Many of these products are also considered 
resistant to market swings. 
During the qualitative evaluation of the annual reports it was noted that companies located 
in countries other than the German-speaking ones, (ICI, AKZO and SOLVAY), reported 
the strategies pursued in greater detail. These strategies were mainly focused on the 
concentration on high-value added, market-intensive products (Akzo). Any s.pecialization 
trends followed were always pursued at the expense of mass production. As a result, Akzo 
d~reased their fibre production from 52 percent of the 1963 turnover to 30 percent in 1984 
and to less than 20 percent in 1993. At the same time, Akzo's share in coatings increased 
from 5 percent of the 1969 turnover to almost ~5 percent in 1993. In order to continue this 
development, Akzo acquired the Swedish Nobel Industries AB in 1993. 
This trend towards specialization can be easily explained by means of the pharmaceutical 
lines of the companies. As shown in Figure 5.2, almost all companies were able to increase 
the pharmaceutical shares in their turnovers. Even BASF and Solvay, whose 
pharmaceutical branches were never part of their historical key areas, are now increasingly 
diversifying their pharmace~rlcal lines. This is one of the few examples where companies 
deviate from the strategy of c~ncentrating on key areas. Thus •. in 1995 BASF purchaSed 
Boots Pharmaceuticals for 2 billion OM. 
The pursuit of the strategy of specialization, however, is no guarantee for success, as BASF 
proved with their commitment in advanced composites. Having purchased said branch 
from Celanese Corp in 1985, BASF was forced to discontinue these activities in 1992 due 
to an unsatisfactory development of demand. In their efforts for better appeal to the 
ultimate'" consumers the companies are now increasingly offering customer services in 
addition to their chemical products. Akzo, for instance, has established special consultancy 
service centers for the purchasers of their varnishes. In addition, special service equipment, 
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Figure 5.2 Share of Pharmaceutical Products for Large Chemical Firms, 1984-1993 -
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e.g. for the exact mixing of varnishes and paints, is offered. ICI, on the other hand, offers a 
comp~ter-aided optimization system for explosions. 
Based on information of the innovating fmns in the CIS sample we can use responses to 
questions lO.c)i-ii of the CIS to get an understanding to which extent the fmns are 
investing in product innovation and in process innovation - measured as the share of their 
total R&D expenditures. As Table 5.3 shows nearly 78 percent of the fmns spend more· 
than 50 percent of their R&D budget on product innovation whereas only 26.6 percent of 
the fmns spend half and more of the budget for process innovation. One interpretation is 
that fmns concentrate overall on specialized products. This is underlined by the fact that 
manufacturers of basic chemicals and of man-made fibres concentrate very much on the 
investment in process innovation which supports djrectly their products. 
Tables 5.4 and 5.5 are based on the R&D expenditures for product innovation arid for 
process innovation. They are underlining the differences in the specialization of the 
segments of the chemical industry.· On the one hand there are more than 60 percent of the 
manufacturers of agrochemicals and of paints and varnishes which allocate 75 percent and 
more of their R&D budget to- product innovations. But only 30.8 percent of the basic 
chemical producers do this and still more different is the profile in man-made fibres. Here 
only 16 percent of the producers spend three quarters and -more of their R&D budget on 
product innovations. As a result more than 15 percent of the manufactures of basic 
chemicals and man.:.made fibres spend 75 percent and more on process innovations. 
The data on the allocation of R&D expenditures for product and process innovation . 
highlight the close interrelation between these two corporate strategies--cost leadership and 
specialization. This interrelation can be elucidated by means of the strategy pursued by 
Solvay: profits from the stagnating core activities (alkaline. peroxide, plastics), where cost 
reduction is a key issue, are used to finance new activities. Solvay accordingly increased 
their share of turnover in the health sector from 6.5 percent in 1984 to more than 17 percent 
irt 1993, while other lines of business remained at an approximate constant. 
5.1~3 Concentration on Key Areas 
Almost all annual reports assign the concentration on key areas and/or key competencies a 
central ·role. with a focus on the achievement of a strong market position and the 
concentration on areas with a high synergistic effect. These are, in fact. strategies that the 
companies keep re~zing with great consistency. Thus, ICI split off all bio-areas (mainly 
. pharmaceuticals and agriculture) and: integrated them into the newly founded company 
called Zeneca, their own subsidiary. Higher flexibility and effectiveness for both 
companies were the stated reasons for this step. However, this also means the end of risk 
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Table 5.3 Distribution of Firms According to their R&D Expenditures Allocated to 
Product and Process Innovation (in percent, 8-country sample) 
Share ofR&D Expenditures Allocated to Innovation Type 
Type of Group 1 Group 2 Group 3 Group 4 Total Number 
Innovation 0-0.25 0.25-0.5 0.5-0.7-5 0.75-1 of Firms 
Product 11.5 10.8 34.8 42.9 555 
Innovation 
Process 46.1 27.2 17.1 9.5 555 
Innovation 
Note: The 8-country sample includes Belgium, Germany, Ireland, Italy, Luxembourg, the 
Netherlands, Norway, and the United Kingdom. 
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Table 5.4 Distribution of Firms According to their Shares of R&D Expenditures for 
Product Innovations by Segment of Industry (in percent, 8-country sample) 
Share of R&D Expenditures Allocated to 
Product Innovations 
Total 
Industry Segment (NACE) Group 1 Group 2 Group 3 Group 4 Number 
0-0.25 0.25-0.5 0.5-0.75. 0.75-1 of Firms 
Basic Chemicals (24.1) 18.4 9.7 41.1 30.8 185 
Agrochemicals (24.2) 6.3 0 31.3 62.5 16 
Paints, Varnishes (24.3) 2.5 7.6 24.1 65.8 79 
Pharmaceuticals (24.4.) 18.7 7.7 26.9 46.7 182 
Soap and Detergents (24.5) 11.0 5.5 31.5 52:1 73 
Other Chemical Products (24.6) 7.9 14.7 33.9 43.5 177 
. 
Man-Made Fibres (24. 7) 20.0 24.0 40.0 16.0 25 
Column·· 98 74 242· 323 737 
Total 13.3 10.0 32.8 43.8 100.0 
Note: The 8-country sample includes Belgium, Germany, Ireland, Italy, Luxembourg, the 
Netherlands, Norway, and the United Kingdom. 
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Table 5.5 Distribution of Finns According to their R&D Expenditures Allocated to 
Process Innovations by Segment of Industry (in percent, 8-~ountry sample) 
Share of R&D Expenditures Allocated to 
Process Innovations 
Total 
Industry Segment (NACE) Group 1 Group 2 Group 3 Group 4 Number of 
0-0.25 0.25-0.5 0.5-0.75 0.75-1 Firms 
Basic Chemicals (24.1) 34.6 32.4· 17.3 15.7 185 
Agrochemicals (24.2) 62.5 18.8 12.5 6.3 16 
Paints, Varnishes (24.3) 67.1 19.0 12.7 1.3 79 
Pharmaceuticals (24.4.) . 52.7 18.1 13.2 15.9 182 
Soap and Detergents (24.5) 53.4 30.1 9.6 6.8 73 
Other Chemical Products (24.6) 48.0 24.9 19.8 7.3 177 
• 
Man-Made Fibres (24.7) 20.0 28.0 36.0 16.0 25 
Column 352 184 119 82 737 
Total 47.8 25.0 16.1 11.1 100.0 
Note: The 8-country sample includes Belgium, Germany, Ireland, Italy, Luxembourg, the 
NetherlaQds, Norway, and the· United Kingdom. 
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sharing for the individual bio and chemical lines, in the past a feature of special importance 
for the chemical lines. 
Sandoz, on the other hand, decided .in 1995, to abandon all lines of business not connected 
with pharmaceutics and/or nutrition. They are now aiming for an exclusive concentration 
on pharmaceuticals and nutrition, since health is ·the common denominator of both 
businesses. The relevant sales profits are to be used for increased future investments in 
gene technology and to· fmance new acquisitions in the areas of pharmaceutics and 
nutrition. 37 This restructuring effort might already be regarded as a sign towards the merger 
between Sandoz and Ciba-Geigy announced in early 1996. The new fliiil Novarns is seen 
among others as an effort focus on core competences in agrochemicals, pharmaceuticals, 
and nutrition. Likewise, Hoechst decided to take equally drastic measures and split off their 
profitable cosmetics line (e. g. Jade and ~chwarzkopf), which was not part of their key 
area. 
5.1.4 The Trend Towards Strategic Co-operation 
Companies are increasingly entering intq strategic alliances in the areas of production and 
R&D. This indicates, however, a quite new development in the chemical industry. Apart 
from co-operation between companies, the co-operation between companies and academic 
institutions\ is of major importance, especially where basic research is concerned. As a rule, 
· strategic alliances are formed to pursue one of the strategies described. 
Co-operation in the area of production usually aims at the grouping together of production 
capacities in order to increase cost efficiency, mostly in connection with the strategy of cost 
leadership. The annual reports supply numerous examples for this: 
• In 1987, ICI and Mits_ubishi Chemicals formed a joint venture for composite 
materials and for the joint performance of field tests. 
• Since 1993, ICI and Kronos have been jointly producing titanium dioxide by 
means of chloride. 
• In 1992, Hoechst and Wacker contributed their respective PVC activities into a 
joint venture. 
A particularly wide co-operation was entered into by Hoechst an~ Schering in 1994, when 
they formed a joint venture called "Hoechst Schering AgrEvo GmbH." This enterprise, 
with a tumov~r of 3 billion OM and approximately 8,000 employees, is the second biggest 
producer of plant protectives world-wide after Ciba-Geigy.38 The objective of this co-
37 Cf. Frankfuner Allgemeine Zeitung dtd. 28 March 1995, p. 21 
38 Cf. Cbemische Industrie 3/94, pp. 28-32 
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operation is the achievement of a so-called "critical size" in the generally shrinking market 
for plant protectives in order to survive both innovative and price competition .. 
The importance of co-operation is ever-increasing, especially in the R&D sector. 
According to another study,39 this is not so much due to increasing R&D expenses, but 
rather has to be contributed to the fact that co-operation enables the individual companies 
to enter into ·new markets, to shorten innovative periods, and to recognize technological 
potentials at ·an earlier stage. The fact that Hoechst AG increased its number of co-
operative agreements from 230 to 380 in the past ten years indicates the dimensions of this 
trend towards co-operation. 40 
The CIS has addressed question number 11 to co-operation arrangements on R&D 
activities with other enterprises or institution. For the .~hemical and the pharmaceutical 
industry of the overall sample 43.4 percent of the fmns report to have such arrangements. 41 
For the 8-country sample the value is 42.2 percent How this is distributed by segment of 
industry shows Table 5.6. The highest intensity of R&D co-operation is found within the -
agrochemical business and the lowest for soap and detergents~ ' 
Information on the location of the co-operation partners is ·provided as well in the CIS.42 To 
check for the intensity by which an arrangeme~t is used in a single location we have 
computed its occurrence for. three major types of arrangement ~e results are shown in 
Table 5.7. The likelihood by which at least one co-operation arrangement is mentioned in 
one of the three major types for one of seven_locations is 85.7 percent43 for agrochemicals. 
The three major types of co-operation we are looking at are co-operation with competitors, 
in the form of research joint ventures, and with universities, government labs, and other 
research institutes. A comparable pattern -- one like in the previous table -- emerges. 
Again, the argochemical segment exhibits the highest intensity of co-operation in all three 
areas. Only at a fJISt glance the intensities for basic chemicals and man-made fibres are 
some what surprising. These segments of industry do rely heavily on cu-uperaliun 
arrangements with universities, government labs, and other research institutes.' Perhaps, an 
even greater challenge . to the chemical industry is the increasing trend . towards 
globalization. 
39 Cf. Fast-Study. p. 32 
40 Cf. Chemische Industrie 1/92. p. 38 
41 It should be recognized that of the 1938 fiJ1JlS all together 34.9 percent provide no information. They are 
the .. missing values". 28.2 percent say that they do apply such arrangement whereas 36.8 percent have no 
such co-operation arrangements. 
-
42 Seven locations are distiguished_. Inside Europe these are regional. national~ E.C .• and non-E.C. and outside 
Europe: U.S.A., Japan. and other. 
43 This overall percentage is not included in Table 5.7. 
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Table 5.6 Share of Finns Applying R&D Co-operation Arrangements by Segment of 
Industry (in percent, 8-country sample) 
Firm has Co-operation Arrangements on R&D 
Industry Segment' (NACE) Yes No 
Basic Chemicals (24.1) 47.1 52.9 
Agrochemicals (24.2) 54.2 45.8 
Paints, Varnishes (24.3) 30.8 69.2 
Pharmaceuticals (24.4.) 52.3 47.7 
Soap and Detergents (24.5) 29.9 70.1 
Other Chemi~al Products (24.6) 38.3 61.7 
Man~Made Fibres (24.7) 33.3 66.7 
Column 308 482 
Total 42.2 57.8 
Note: The 8-country sample includes Belgium, Germany, Ireland, Italy, Luxembourg, the 
Netherlands, Norway, and the United Kingdom. 
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Table S. 7 Distribution of Firms According to the Type of R&D Co-operation they 
Practise by Segment of Industry (in percen~, 8-country sample) 
Type ofR&D Co-operations 
Arrangements with 
Industry Segment (NACE) Arrangements with R&D Joint Government Labs, 
Competitors Ventures Research Institutes, 
Universities etc. 
Basic Chemicals (24.1) 17.6 23.1 71.8 
Agrochemicals (24.2) 50.2 40.0 75.0 
P~ts, Varnishes (24.3) 0 33.3 50.0 
Pharmaceuticals (24.4.) 31.4 20.0 66.7 
Soap and Detergents (24.5) 12.5 0 50.0 
Other Chemical Products (24.6) 12.7 12.5 64.8 
Man-Made Fibres (24. 7) 16.7 0 83.3 
Column 47 20 167 
Total 18.7 20.6 66.5 
Note: The 8-country sample includes Belgium, Germany, Ireland, Italy, Luxembourg, the 
Netherlands, Norway, and the United Kingdom. 
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5.1.5 The Trend Towards Globalization 
Conclusions, can be drawn as to the extent of globalization of certain chemical companies 
from the layout of their annual reports, which, as a rule, give a de_tailed account of regional 
developments (such as Europe, North America, Latin America and Asia). The trend 
towards globalization shows itself in: 
• corporate efforts to achieve added increased rates of turnover outside Europe (e. 
g. in Asia and the USA), since only small growth rates are to be expected within 
Europe; 
• investments in new production plants being placed mainly in close proximity to 
the main trading areas (such as Asia);· 
• R&D increasingly being moved into the proximity of major customers, and/or 
areas with more favourable R&D con,ditions (su~h USA conce~g gen~ 
technology). 
The companies of Switzerland, as well as ICI, rank among the geographically most 
diversified companies. Thus, Ciba-Geigy and Sandoz between them hold approximately 40 
percent of the to~ European turnover and about 30 percent of the North ~erican one. 
Solvay and Akzo, on the other hand, are not as geographically diversified, but Akzo is 
increasingly trying to improve their "geographic mix'ture," as was explicitly stressed m 
their 1993 annual report. 
Geographic diversification is usually realized by way of acquisition, as is the case with the 
latest Hoechst acquisition. Hoechst purchased the American company, Marion MereU:. 
from Dow for more than 10 billion DM. With this purchase, Hoechst became one of the 
four major suppliers of pharmaceutical products in the USA and, thus, managed to 
considerably strengthen their formerly weak position in the US market--one of the most 
importarit pharmaceutical markets world-wide. 
' . . 
The foreign proportion of R&D in promising fields, however, developed in an even more 
dynamic manner than the foreign share in turnover. The majority.of the companie~ actively 
engaged in gene technology carry out their research in the USA, while as far as material 
research is con~emed, numerous companies prefer to make Japan their location. Apart from 
the legal framework, the contact with leading academic resear~h facilities for the respective 
fields is an important decisive factor for the choice of a location. 
Bayer, for instance, established their new pharmaceutical research centre (Miles 
. Laboratories) in West Haven (USA), ·while their new plant protection research center was 
built in Yuki (Japan). Although Europe, with its 70 percent of the R&D budget, is still their 
strongest R&D location, Bayer plans to ·expand its US and Japanese locations. In the. 
mediu~ term, their foreign portion of R&D is supposed to increase to approximately 50 · 
. . . 
percent, a quota that has already been reached by the two Swiss companies. 
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The reaction of Hoechst to this increased internationalization consists of a supraregional 
research concept. Thus, Hoechst and mM carry out joint research with an emphasis on 
photoresisters in the USA, while Japan is the best possible location for new liquid crystal 
systems for large screens. For ceramic superconductors, however, the company decided on 
Germany as their favorite location.44 
To test for the trend of increasing globalization of markets we used CIS data for question 5 
(,objectives of innovation"). By grouping together those firms which perceive the presence 
in global markets as ,very significant" or ,crucial" according to turnover size groups of 
fmns the following obvious pattern emerges in Table 5~8. A share of 50 to 60 percent of 
the small and medium· sized fmns view the creation of national markets as important 
whereas for the largest group (turnover more than 50 million ECU) only 40.6 percent of_the 
fmns perceive the importance of crearing nationally new markets. For the creation of new 
markets within Europe aU-shaped relationship holds, that is, the smaller (64.9 percent) and 
the largest firms (59.4 percent) perceive that as an important objective. The range of the 
groups inbetween is 52.1 to 55.8 percent. The importance of being present in the North 
American market shows a linear increase with fmn size, from 10.9 percent in the smallest 
size group to 29.1 percent for the largest fmns of the chemical industry. _ 
5.2 Conclusion 
In spite of the corporate p~flles partially differing information, quite a few common 
features concerning corporate and innovative strategies could. be established in particular 
when CIS data is used to complement the picture and to check for regularities in the whole 
industry. It became obvious the· investigated companies operate under similar competitive 
conditions. The fact that the companies concentrate on certain mas.s products rendering a 
strong market position, was particularly noticeable. All the companies studied are also 
involved with highly refmed products. 
This part of the study clearly reflectS thf: trends already established within the framework of 
the innovation counting approach. The strong shifting of turnover shares from mass · 
products to highly refined products indicates how drastically the companies carry out their 
restructuring proces~es. Thus, the annual reports include many examples for capacity 
decreases concerning mass products. In the area of highly refmed products, on the other 
hand, numerous acquisitions, some·of them outside Europe were recorded, which shows an 
increasing globalization of corporate activities. This globalization is further accelerated by 
the innovation barriers preva.illi)g in many Emopean countries. How this is reflected in the 
CIS data bases will be investigated in some detail in the next section. 
44 Cf. Chemische Industrie 1/92, p. 38 
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Table 5.8 Globalization of Markets: Distribution of Firms According to the Objective 
"Creation of New Markets" by Turnover Size Groups (in percent, 8-country 
sample, pharmaceutical industry excluded) 
Size Group by Turnover (thousand ECU) 
1 2 3 4 5 
· Creating New Markets: (0-499) (500- (10,000- (100,000.:. (500,000+) 
' 9,999) 99,999) 499,999) 
Nationally 88.9 60.3 49.7 50.5 44.8 
within the European Community 11.1 61.0 55.4 51.6 63.2 
in North America 11.1 11.6 13.6 16.7 29.7 
Note: The 8-country sample includes Belgium, Germany, Ireland, Italy, Luxembourg, the 
Netherlands, Norway, and the United Kingdom. The share of those firms was taken for 
firins for which the creation of new markets is "very significant" or "crucial". This then 
was related to the total number of firms responding to the question. 
6 An Analysis of the CIS_ Data 
6.1 The Chemical Industry in the CIS Sample 
The CIS sample for the chemical industry inclU:des observations from 13 countries (see: 
Table 6.1 and 6.2) . Since December 1995 a ,cleaned" data set has been available.45 The 
total n~ber of firms classified according to NACE 24 into the chemical industry is 1938. 
Accoding to turnover, employment, and R&D, these firms are distributed over ~ 
countries as follows ·(see: Table 63). The largest number of observations came from Italy 
with 791 firms and the fewest from the U.K. with nine fmns. This large difference in 
participation in the CIS should be recognized in the course of interpretation and 
explanation of the statistical results. According to Eurostat46 the data for 10 countries is 
comparable. Data from Greece, Portugal, and the U.K. is not co,~parable. The Greek and 
Portuge8e data includes only information on those firms which undertook innovations and 
the number of U.K. firms is very small. Furthermore, the some answers to CIS questions in 
the data for France are completely missing. Among others the figures for R&D. 
For the type of intra-industry analysis we are undertaking it is important to analyse the 
industry according to . their main product groups. This . is because in their iimovative 
activities fmns exhibit significant differences regarding these groups. Thus, our analysis 
will focus on the comparison of the 13 countries and on seven major product groups, the 
so-called segments or the chemical industry.47 
. . 
6.2 Organizational Characteristics Affecting Innovation 
6.2.1 Objectives of Innovation 
The. objectives for innovative activity are in two ways important· First, they are part of the 
corporate strategy. and insofar they influence the way firms are organizing their innovation 
activities. Second,. if environmental changes outside_ the.fmn seem to require innovation by 
the firm, preferences of their employees may change and as such the innovation objectives 
of the fmn. Jewkes, Sawers, and Stillennan (1960) and other cases studies of innovations48 
45 The lastest corrections from Eurostat regarding the CIS data· set beared the date Marcfi 7, 1996. 
46 See Eurostat, Statistik kurzgefasst, 1996, No.2, p:l. 
47 Since the whole CIS venture might be regarded at this point in time as an approach to provide 
opportUnities for the srudy of the competitiveness of European industry we decided to use the maximum 
amount of iii formation available for our·srudy. That is, we use the for the intra-industry analysis an 8-country 
sample incl\lding Belgium, Germany,.Ireland, Italy, Luxembourg, the Netherlands, Norway, and the United 
Kingdom. In case data for France is available it becomes the 9-country sample. 
48 See e.g. Albach (1994) for recent cases studies on basic innovations and for the imponance of the 
organization for successful innovation. 
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Table 6.1 Distribution df Chemical Finns in the CIS Sample by Country and Size 
(in absolute numbers and in percent) 
Finn Si7.e Grou12s in Em~lo~cc.o; 1992 
Country 1-4 S-49 50-249 250-499 500-99'-J HXX) and 
. employees . employees employees employees employees more 
emeloyecs 
Belgium IS 19 22 8 16 
18.8 23.8 27.5 10.0 20.0 
Denmark 7 18 9 3 2 
17.9 46.2 23.1 7.7 5.1 
France 68 81 36 24 26 
28.9 34.5 15.3 10.2 11.1 
. Oennany 2 49 42 30 24 32 
1.1 27.4 23.5 16.8 13.4 17.9 
Greece 5 7 13 7 2 
14.7 20.6 38.2 20.6 5.9 
Ireland 43 46 10 
43.4. 46.5 10.1 
Italy 1 347 318 58 36 31 
0.1 43.9 40.2 7.3 4.6 3.9. 
Luxenibourg 9. '2 
81.8 18.2 
Netherlands 1 54 127 14 12 11 
o.s 24.7 58.0 6.4 s.s . 5.0 
Norway 1 10 3 4 2 
5.0 50.0 15.0 20.0 10.0 
Portugal 13 19 10 s 1 
27.1 39.6 20.8 10.4 2.1 
Spain 63 71 23' 11 5 
36.4 41.0 13.3 6.4 2.9 
United 3 2 3 1 
Kingdom 33.3 22.2 33.3 11.1 
All Countries 
Total 
80 
4.1 
39 
2.0 
235 
12.1 
179 
9.2 
34 
1.8 
99 
5.1 
791 
40.8 
11. 
0.6 
219 
11.3 
20 
1.0 
48 
2.5 
173 
8,9 
9 
o.s 
193J 
100.0 
Note: 1be overall sample includes 1938 firms. One fum is excluded since the information on fmn size 
is not available. 
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Table 6.2 Distribution of Chemical Firms in the CIS Sample by Country and Segment of Industry 
(in absolute numbers and in percent) 
NACE 
Counlly 24.1 24.2 24.3 24.4 24.5 24.6 24.7 
Basic Agro- Paints. Phanna- Soap, Other Man-Made 
Olcmicals chemicals Varnishes ccuticals Detergents Chemical Fibres 
Products 
Belgium · 36 1 7 15 5 12 4 
45.0 1.3 8.8 18.8 6.3 15.0 5.0 
France 48 8 38 65 40 33 3 
20.4 3.4 16.2 27.7 17.0 14.0 1.3 
Gennany 61 1 21 26 30 33 i 
34.1 0.6 11.7 14.5 16.8 18.4 3.9 
Ireland 10- 4 9 48 10 17 1 
10.1 4.0 9.1 48.5 10.1 17.2 1.0 
lraly 186 16 118 199 .106 135 31 
23.5 2.0 14.9 25.2 13.4 17.1 3.9. 
Luxembourg ·3 2 1 1 3 1 
27.3 18.2 9.1 9.1 27.3 9.1 
Netherlands 45 5 9 17 10 128 6 
20.5 2.3 4.1 7.7 4.5 58.2 2.7 
Norway 10 4 2 .2 2 
so.o 20.0 10.0 10.0 10.0 
United 1· 1 
Kingdom so.o 50.0 
All Countrys 
Note: Due to a lack of informaljon the sample for the analysis according to the 3~gt NACE 
classificalion is smaller than the overall sample. 
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Table 6.3 Descriptive Statistics for Turnover, Employment, and R&D of the Firms in the Sample 
by Country 
Country BEL DK ESI• fR GER GR IRI. I'll. 
' 
Turnover 1992 In 
thousands of ECU 
Sum 27.483,799 2,100,298 ;,464,803 24,939,312 46,254,241 456,978 2,043,346 36,163,844 
Mean 343,547 53,853 31.588 106,124 258,403 13,440 20,639 45,719 
Median 56,017 24,398 10,690 20,804 31,249 8,799 7,756 11,128 
Minimum 1,081 2,307 377 1,031 147 20 657 13 
Maximum 5,22T.H49 6Ci6,732 882,936 3,295,223 19,356,Ci33 83,024 123,567 2,238,076 
Tumover per 232 135 161 230 139 71 201 227 
Employee 
l~mp1oyecs 
-
Sum 118.113 15,486 33,865 108,022 332,812 \ 6,.362 10,152 158,858 
Mean 1,476 397 195 45•> 1,859 187 ' 102 200 
Median 302 150 87 123 220 17M 59 58 
Minimum Ill ll 9 12 3 I 10 4 
Maximum 31,401 5.850 2,186 12,540 136,:\94 804 4K6 9,321 
R&U 1992 in 
t 1umsunds of l~C U 
Sum IS88,921 2(13,039 811,033 - 2,2112,073 2,1181 51,K55 l)l)l) ,97 .\ 
Mean 15,32(> 7,736 1(,C) I;,IS42 115 771 3,257 
Mcdi;m 1,516 1.663 302 - 7111 K2 L\2 391) 
Minimum 20 128 () - 0 4 1 6 
Maximum 150,(>M 66,972 8,977 - 971S,()(,(, 41J3 i9,718 87,159 
R&l> per 7 17. 2 . 6 II 5 6 
- lfulQllly_~'\: L_______.___._~ 
-
LliX NL NOR I' IlK 
141.396 27,137,594 2,112,214 1,306,546 500,931 
12,854 123,352 105,610 27,219 55,647 
3,586 13,692 50,346 15,ol8 20,538 
106 440 2,407 0 2,020 
101,734 11,506.493 532,056 170,156 296,307 
314 264 300 122 83 
450 102,642 7,032 10,664 5,974 
40 466 351 222 663 
15 95 207 154 124 
5 0 lO 7 21 
228 23,(144 1,279 1.614 4.406 
Hl7 1,105,778 K8,l1Kl 10,826 14.548 
107 7,898 5,506 3.\8 l.IS liS 
. 368 1.219 150 1.247 
107 ' 0 22 (, 14 
107 253,480 52,0.\8 2,81)4 7,456 
0 lO 12 1 2 
emphasized the importance of the organization of innovations and the firm's environment 
in the innovation process. These studies indicate that the primary limitation on a firms 
effectiveness in innovation are neither costs nor the technical knowledge required. Rather, 
the main limitation seems to be their ability in recognizing needs and demands in their 
extemal environment which is in tum detennined by the innovation objectices of the fmn. 
Therefore it is important to consider the objectives ~f innovation in some detail. 
The purpose of this section will be to identify the innovative objectives that f1rms have in 
the chemical industry and to illustrate how these objectives vary across fmns, as well as 
across countries. The CIS (section Ill) provides a subjective evaluation by firms of their 
innovative objectives, ranging from 1, which refers to "Insignificant," to 5, for "Crucial." 
Possible objectives for innovating include "extending the product range," "creating new 
markets" and "lowering production costs." We will compare the mean values and standard 
deviations pf all of the more specific responses within' each main category. We will then 
compare these means across geographic regions, to detennine which objectives are the 
most important in which countries. For that purpose we will use a graphical ranking device 
which was already applied by 'll:.W Mannheim in their analysis of the German innovation 
. surVey.49 
To check for the appropriateness of the items of the CIS with respect to the objectives of 
innovation we apply in a non technical way factor analysis.S0 Ta~le 6.4 indicates that the 
factor loadings based qn principal component an~ysis with a varimax rotation exhibit a 
structure similar to the items as organized in the CIS questionnaire. Five factors are 
identified using factor loadings higher than 0.45. Tables 6.5 and 6.6 list the objectives of 
innovation grouped according to these five factors by coun~ and by segment of industry. 
The factors then were ranked based on the overall mean for the variables of this factor. The 
ranking over all countries points to the ,extension of local markets" as the most important 
bundle of innovation objectives. The circle • indicates the three most important objectives 
and the circle o the three least important ones in the table. Increasing and maintaining 
market share is the crucial objective for innovative effort in the European chemical 
industry. Of similar importance is to improve product quality by means of innovation. 
Creating new markets in Japan is the least important goal. One exception regarding the 
overall quite homogeneous goal structure is France. The French fmns have the highest 
preference for using innovative effort in order to extend the product range outside the main 
product field, that is to aim at product diversification. Closely related to the question of 
· 49 See Felder, Harhoff, Licht, Nerlinger and Stahl (1994), Innovationsverbalten der deutscben Wirtscbaft. 
so Non t~bnical way means that we will not repon the statistical properties of the analysis and that we will 
extract more factors than according to the Kaiser criterium should be extracted. The Kaiser criterium limits 
the extraction to factors representing eigenvalues greater than 1 because for values of 1 and less the use of 
variables themselves is statistically more appropriate. 
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Table 6.4 The Structure of Objectives of Innovation 
Variahle 
Replace pnxJucts ~ing phased out 
Extend product nUlge: 
within main nroducl field 
Extend product r:mgc: 
outside main nroduct field 
Mean Std.l>ev. Process Innovation ind. 
environmental issues 
(). ().t() 
0.044 
Opening up of 
Global Markets · 
0.207 
()~ 194 
Extension of · 
Local Markets 
Prudut;t 
Innovation 
Produt;l 
L>iversili-cation 
146 
0.120 
0.117 
OJ'J 
0.086 
0\ 
\J.I 
· Table 6.5 The Importance of Objectives of Innovation by Countries 
All Countries BEL DK 
Exte:n~ion of l.ocal marke:ts 1 I 1 
lncreusing or maintaining market share • • • 
Creating new markets: nationally 
Creating tiew markets: within the Europem1 Community 
t•ruduct Innovation 2 3 2 
Replace products being phased out 
Extend product runge: within main product field • 
t•roct:Ss lnnuvatiun Incl. environmenhellsuses 3 2 3 
Improve production flexibility 
Reducing share uf wage costs • 
Reducing materials consumption 
Reducing energy consumption 
Reducing product design custs 0 0 
Reducing ·production lead times • 
Reducing envirunmental dmnage 
Improving pruduct qmtlity • • • 
Improve working l:unditiuns/S:alcty 
.. roduct Uive:rsillcatlon 4 4 4 
Extend pruduct runge: outside main product field 
ol)t!lling Uf) of Global Markets 5 5 5 
in North America 0 0 0 
in Japan 0 0 0 
in other countries 0 
-- ------------
-
ESP FR fiER GR IRL 
1 3 2 I I 
• • • • 
• • 
3 2 I 
-
2 
0 
• • • ~ 
2 4 3 2 3 
0 
0 0 
0 • 
0 0 
0 
• • • 
4 I 4 
-
4 
0 • 0 
-
5 5 
-
.5 
0 0 
0 .o 
0 
Note: The ranking of the objectives is based on the mean value of tJ1e respective cluster of objectives. 1 represents the highest ranking. 
The circle • indicates the three mosi important single objectives and the circle 0 the three least important ones . 
. 
---- ----~· --------
ITL I.UX NL NOR p tJK 
I 2 I I I I 
• • • • • • 
• 
2 3 2 2" 3 2 
• • 
3 I 3 3 2 3 
• 
-. 
0 
0 0 0 0 0 
• 
• • • • • • 
• 
4 5 4 5 5 .. 
0 0 0 
5 4 5 4 4 5 
0 0 0 0 
0 0 0 0 
0 
0\ 
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Table 6.6 Importance of Objectives of Innovation by.Segments of Chemical Industry 
NACE 
Chemical 24.1 24.2 24.3 24.4 24.5 
Industry Uasic Agro- Paints, Pllann:accu- Soap, 
' 
without Chemicals chemic:als Varnishes ticals Detergents 
Pharma-
ceuticals 
l~xtcn.~ion ul' Local Markets I I I I I I 
Increasing or maintaining market share • • • • • • 
Creating new markets: n:tlinnally I 
Creating new markets: within the Eumpc:m 
-
Community 
l1ruduct Innovation l 3 l l l l 
' 
Replace pr~xlucts being pha.o;ed out 
Extend product range: within main product 
lield • • • • • 
l1ruc~s Innovation incl. environmental isuses 3 l 3 3 3 3 
Improve produ(.1ion flexibility 
Reducing share of wage costs 
Reducing materials consumption 
ReduCing energy consumption 
Reducing pnxluct design costs 0 ·o 0 
Reducing prcjductinn lead times • 
Reducing environmental d:mmge 
Improving product quality • • • • • • 
Improve working dmditions/Salcty 
. 
l1ruduct l)iversilicutiun 4 4 4 4 4 4 
Extend product nmge: outside main product 
field 
Opening up of Global Markets . s ·s s s s s 
in North America ' 0 0 0 0 0 0 
in Japan 0 0 0 0 0 0 
in other counh'ies . 0 0 0 
- --~-
Note: The ranking of Ute objectives is based on Ute mean value of Ute respective cluster of objectives. I represents Ute highest ranking. 
The circle • indicates Ute three most important single otjcctives and Ute circle 0 the Uuee least important ones. 
24.6 24.7 
uthcr Mmt-Madc 
chemical Fibres 
Products 
I I 
• • 
l 3 
• 
3 2 
0 
• •  
4 s 
• 0 
I 
I 
! 
s 4 
0 0 
0 0 
objectives of innovation is the question of how firms scan their environment in order to 
pursue their innovation objectives. 
6.2.2 Information Sources 
There is general agreement that important information for ·innovation in the chemical 
industry has come from basic research in chemistry .. This leads to a related question 
whether one can isolate technology-push or demand-pull factors as the major source of 
innovation. Empirical research showed that both are important For example, Freeman 
(1968, 1974) provided evidence using 810 innovative chemical processes that the user as 
the source of information for these innovations made up a share of 70 percent whereas only 
30 percent of the ideas came ~om the innovating fmn. Along these lines von Hippel (1978, 
1988) developed his theory of the locus of innovation, that is, the likelihooq for the success 1 
of innovation projects increases when they are a result of interaction with customers. How 
the importance of external sources of innovation is evaluated by the fmns of the European 
chemical industry today, will be show with the following tables. 
Again, we used factor analysis to measure the underlying structure of the importance·of the 
sources of information. We extracted three factors which·are shown in Tables 6.7, 6.8, and 
6.9. The most ~portant factor covers all external sources of information, which we simply 
labelled as ,other fmns"St. The day-to-day innovation business may have led to the fact 
that science-based sources are regarded .as less important This pattern results for the 
countries as well as for the segments of industry. The highest importance was still 
attributed to the variable ,,internal sources from within the fmn" (mean score 3.7). Next .. 
follow ,clients and customers" with 3.4 and the least important source are ,technical 
institutes" (1.8). We can draw' the conclusions that the locus of innovation is most 
commonly within the innovating fmn, but a second locus is certainly with the customer. 
The CIS data for the chemical industry $"eady underlines the importance of a network 
approach to the souces of innovation. This is at least what oue gets when considering again 
the various arrangements wed by the fmns in order to achieve R&D co-operation (see 
Section 5.1.4). Furthermore, the network approach might also help to overcome some of 
the barriers to innovation. 
6.2.3 Barriers to J,.novation 
This section is devoted towards identifying the major factors impeding innovative activity, 
both at the finn and country level. Section VI of the CIS provides subjective responses 
evaluating "Factors Hampering Innovation" on the 1-5 scale. Possible factors range from 
economic factors, including "excessive perceived risk" and "lack of appropriate sources of 
Sl We should have labelled this factor as "external sources.non-science based". 
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Table 6. 7 The Structure of Sources of Information for Innovation 
Variable 
Internal Sources: within the enterprise 
Internal Sources: witin the group of 
enterprises 
Suppliers of materials and components 
Suppliers of equipment 
Clients or custumer 
Competitors in your line of business 
Consultancy finns 
Universities/higher education 
· Government laboratories 
Technical institutes 
Patent disclosures 
Professional · conferences, meetings, 
1 professional journals 
Fairs/exhibitions 
Mean Std.Dev. Other Finns · Science Internal Sources. 
Patent Disclosures 
3.648 
1.948 
2.891 
2.862 
3.364 
2.876 
1.971 
2.047 
1.824 t .o21 o.111 \\:i!Ii!@IPH~X o.224 
1.775 
2.287 
2.942 
2.738 
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Table 6.8 The Importance of Sources of Information for Innovation by Countries 
All Countries BEL DK ESI> r·n GER GR U{L 
Other lirms 
' 
I 2 I I 2 I 2 I 
Suppliers of materials and components • 0 0 
Suppliers of equipme~ll 
ClienLc; or custumer • • • • • • • • 
Competitors in your line of business . • • 
. 
Professional coi1ferences, meetings, professional • • • • • journals 
Pairs I exhibitions • • 0 
Internal sources, I•atent disclosures 2 1 2 2 1 2 1 2 
Within the enterprise • 
·-
• • • • 
Within the group of enterprises 0 0 0 
Patent disclosures 0 
Science 3 3 3 3 3 3 3 3 
Corisltancy finns 0 0 0 0 
Universities I higher education 0 0 0 
Government laboratories 0 0 0 0 0 0 
Technical institutes 0 0 0 0 
Note: The ranking of the objectives is'based on the mean value of the respective cluster of objectives. I represents the highest mnking. 
The circle • indicates the three must important single objectives and the circle 0 the three lc~1st important ones. 
ITL LUX NL NOR p UK 
I 1 2 I I I 
• • • 
• 
• • • • 
• • 
• • 
2 2 1 2 2 2 
• • • • • • 0 0 0 0 
0 
3 3 ·3 3 3 3 
0 0 0 0 
0 0 
0 0 0 0 
0 0 0 
0\ 
co 
•, 
Table 6.9 The Importance of Sources of Information for Innovation by Segments ~f Chemical Industry 
NACE 
Chemic<tl 24.1 24.2 24.3 24.4 
Industry Basic Agru- Paints, Phnnnaceu-
' 
· without Chcmic:als chemicals Varnishes ticals 
Phannaceu- -· 
ticals 
Other 11rms 1 1 2 1 1 
Suppliers of materials and components • • • 
Suppliers of equipment 
Client~ or custumer • • • • • 
Competitors in your line of business 
Professional conferences, meetings, professional • • journals 
Fairs I exhibitions 
lnternul suurct!S, l•atent disclosures 2 2 I 2 2 
Within the enterprise • • • • • 
Within the group nf enterprises 0 
Patent disclosures 
Science 3 3 3 3 3 
Consltmu:y linns 0 0 .o 
Universities I higher edm.:ation 0 
Govenunent laboratories 0 0 0 0 0 
Technical institutes 
- 0 0 0 0 0 
-- -------- ----
-----
Note: The nUJking of the objectives is based on the mean value of the respective cluster of objectives. I represents the highest ranking. 
The circle • indicates the three most important single objectives and the circle 0 the three least importalll ones. 
24.5 24.6 24.7 
Soap, other Man-Mm.Je 
l>~tergents chemical Hbres 
Products 
1 l I 
• • 
• • • 
• 
2 2 2 
• • • 
! 
3 3 3 I 
0 
0 0 
0 0 0 
0 0 0 
-----------
fmance," to fmn-specific factors, including "lack of innovative potential in the fmn," "lack 
of skilled personnel," and "lack of information." Other reasons, such as "lack of 
technological opportunities" and "innovation too easy to copy" are also explored. 
To determine which of these factors constitute the most significant deterrents to 
undertaking innovative activity, we had in mind to estimate a simple ordinary least squares 
regression model, 
Y*=~X +£ 
where 
y* is the ranking of each type of barrier to innovative activity, 
X is a vector of exogenous variables including fmn size and dummy variables representing 
the specific country, 
. ' 
,l 
8 <is the estimated coefficient, and 1 
.£ is the stochastic· disturbance with an expected value of 0 and variance of a 2 • 
After having checked the CIS data and run the frrst regressions we had to recognize that the 
variation in the data was to small to use regression analysis in the frrst place. This had led 
us to apply again faetor analysis to get an idea of the structure of impediments and factors 
hampering innovations. The correlations between the variables and the factors - our factor 
l1>adings --are quite high and provide a clear factor structure (see: Table 6.10). Using this 
structure of the barriers to innovation the dominance of the factor ,,fmancial risk and lack 
of capital" becomes obvious. The ranking of the factors by countries and by segments of 
industry is shown in Tables 6.11 and 6.12. There is nearly no difference between the fmns 
located in the different European countries, except Luxembourg. For France no data is 
available. The picture becomes still clearer if we analyse by segment of industry. There we 
fmd a uniform ranking in the evaluation of ,,fmancial risk and lack of capital". But we have 
to admit, that the highest averages of the single variables are located ne~by ,,3 ·' which 
implies literally translated a ,,moderately signifi~ant" barrier to innovatio~. 
,,Innovation cost to high" has an average of 2.8 and the ,,lack of appropriate sources· of 
fmance" of 2.6. Thus, cost is one of the most obvious barrier to innovation in the chemical 
industry. The cost might be attributed to the whole number of items of innovation costs but 
in particular to R&D effort when it comes to more radical innovations. If this is 
comple_mented by a lack of fmancial capital then both factors presumably interact in the 
same direction, and then, regardless of prospective profitablity of the innovation, the 
barrier might become insuperable. This result clearly demands some policy considerations. 
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Table 6.10 The s ·tructure of Factors Hampering Innovation 
Std.Dcv. V&triablc Mean Internal I f-inancial I Competi-tive 
Implen_1cn-tion Ris~ ·~nd _Lack Risk 
I~ ask ol Capital 
Economic factors: excessive 2.2191 1.1791 o. 5 39t :::::::r:n:::::t::: :::u:g~:~J41 0.1991 
1crcci vcd risk 
Economic factors: lack of 2.625 1.32~1 0. 16661 )))/fff/{0 /1401 (JltJII 
tc sources of finance 
I ~conomic factors: innovation costs 2J~41 1.336 0.294 ·:::::: ::::::)~i/{))([8.9.:5. 0.170 
:-:·:<·::·:.:·:·:·:-:·:·:·:·:·:·:·:·:·:·.·:·:·:-:.:-::-;.. 
too high >~?/:\~/:~:~:~:~:~~rrrrt~t:~ . 
Economic factors : pay-off pcricxJ of 2.651 1.314 0.352 .:}}f{\\\\Jl6~tt 0.2XI 
innovation too lo 
Enterprise's innovatio potential too I 2.1 u~l t.l26ltt::::::::::m::::::::::m:ttofl231 0.3151 -o.oool 
small 
ltacl 
---4 
0 
Lack of 
opportunities J(,r co-
opentt ion and 
technical service 
-0.0471 
0.3181 
0.2011 
0.0221 
0.2071 
f-irst-Mover 
lmpcdimen t 
0.0321 · 
0.1061 
0.1251 
0.1281 
0.1991 
Lack of 
. Technological 
( >pportunities 
0.053 
-0.063 
0.055 
0.184 
· 0.06X 
0.059 
0.166 
-:J 
...... 
Table 6.11 The Importance of Factors Hampering Innovation by Countries 
- ---- ------------
All Countries BEL I>K ESP I~R GER GR IRL 
Financial Risk and l,.ack of Capital 1 1 1 1 . 1 1 1 
Excessive perceived risk • • Lack of appropriate sources of finance • • • • 
lnno_vation costs too high • • • • • • -. 
Pay-off period of innovation too long • • • • • , 
lnt~rnal Implementlun Risk 3 3 l 3 . 4 3 2 
enterpris's innovation potential too small • 
Lack of skilled personnel 
Lack of infonnation on technologies . -
Luck of infonnntion on markets 0 0 
Innovation to hard to control 0 
Resistm1ce to change in the enterprise 0 0. 0 0 0 
. 
ComiJ~titive Risk l 2 3 4 . -2 2 3 
Innovation too easy to copy 0 
Legislation, nonns, regulations, stmtdards, taxation •• • 
l.uck of custumer reponsivness to new products m1d 
pmcesses 
Uncertainly in timing 'or innovation 
Lack of OIJIJorhmities for Co-op~ration and 4 5 5 2 . 5 4 5 
Technical Service 
- Deficiencies in the availability of extcnmltedmical 0 0 0 0 
services 
- Lack of opportunities for cooperation with other linns 0 
and technological institutes 
Lack ofT~chnological Opportunities 5 4 4 6 . 3 . 4 
Lack of technological opportunities 0 0 
First-Mover ImrJediment 6 6 6 5 . . . 5 
No need to innovate due to earlier innovations 0 0 0 0 0 
-----------~-----
------- --
Note: The ranking of the objectives is based on d1e mean value of the respective cluster of objectives. I represents the highest ranking. 
The circle e indicates d1e three most important single objectives and d1e cirCle 0 the three least important ones. 
Due to U1e number of equal mean values for the Netherlands U1e U1ree least important objectives are not indicated . 
ITL 
1 
• 
• 
• 
3 
0 
2 
4 
5 
0 
6 
0 
..-.......~---- - ------- -.-~----- ·- -,.---------------------------------------------------------
LUX NL NOR p UK 
2 1 1 1 1 
• • • 
• • 
• • • 
• 
3 2 3 2 2 i I 
• • 0 • 
• • 0 
I 
0 0 
4 3 6 - 3 
-0 0 
0 
6 3 4 - 5 
0 
0 0 
3 3 2 3 3 
0 
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• .o 
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Table 6.12 Importance of Factors Hampering Innovation by Segments of Chemical Industry 
NA('E 
Chemical 24.1 24.2 24.3 24.4 24.5 
Industry without Basic Agro-chcmicals Paints, Phamtaceu- Soap, 
l'hamt:tt:cuticals Chemicals Varnishes ticals I >etergents -
' 
l<'in.-nclul Risk and Lack uf Capital t t t - 1 t 1 
Excessive perceived risk 
Lack of appropriate sources of finance •- • • • • • 
lmiovation costs too high • • • • • • 
Pay -off period of innovation too long • • • • • • 
lnternallmplemention Rlo;k 2 3 2 ·3 3 3 
Enterpris's innovation potential too small 
Lack of skilled IX.."fsonncl 
Lack uf information on technologies 0 0 
Lack of infonuation on markets 
Innovation to hard tu control 
Resistance io change in tbe enterprise 0 0 0 
Com(lctitive ((isk J 2 4 2 2 2 
Innovation too easy to copy 0 
Legislation, norms, regulations, standards, 
taxation 
Lack of custumer 1\:pnnsivncss to Rew pmducts 0 0 
and processes 
t lncl!:rtainly in tinting of innovation 
Luck of O(lpttrtunitics for Co-opcrution und s 5 3 s· .. s 
'l'cclmicul Service 
- Delicicncics in the <~Vailability of I!:Xternal 0 0 
technical services 
- Lack of opportunities for cooperation with 
other fimts and technological institutes 
J?irst-Movcr lm(tcdiment 6 6 6 6 6 6 
No need to innovate due to earlier innovations 0 0 0 0 0 
Lack of Tccbnologicul O(J(Jortunitics .. 4 s 4 s 4 
Lack of technological opportunities 0 0 0 
Note: The ranking of the objectives is based on the mean value of d1e respective cluster of objectives. I represents the highest ranking. 
The circle • indicates dte three most important single objectives and the circle 0 the three least important ones. 
24.6 24.7 
uther chemical Man-Made 
Pn11.lucts Fibres 
1 t 
• 
• • 
• • 
2 .. 
• 
0 
3 2 
4 s 
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0 0 
s J 
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6.3 Innovative Performance 
6.3.1 Measuring Innovative Activity 
The CIS covers a few input and output measures of innovative activity of the fmn. The 
following measures52 are of interest for this study: 
• Firm is an innovator or not Infonnation is provided on whether the fmn has developed 
or introduced any technologically changed products or any technologically changed 
processes during 1990-1992. 
• Expenditures on activities related to product innovation and the fmancial effort 
dedicated to pro_cess innovation. 
• The innovative output, that is, the outputs of incrementally and radically changed 
products, and sales flowing from these products.· 
6.3.2 The Distribution of Firm Innovative Activity within the Industry 
6.3.2.1 Innovating Firms 
Innovative output is due to a number of factors like technological competence, market 
opportunities, and the opportunity to appropriate returns. By simply comparing the share of 
innovators to non-innovators in our sample these factors cannot be isolated. As seen from 
Table 6.13 with the shares of product innovators per country show, there are significant 
differences. They are probably due to the specificities of the country samples and to a 
measurement bias resulting fron the short period (1990-1992) were fmns ought have to 
report any changed products or processes. Since the table exhibits also the share of process 
innovations -- which is highly correlated with the process innovations -- we expect that 
there is also a country bias. 
For the purpose of comparison we should exclude the Greek and Portuguese finns because 
these fmns ought to be all innovators. Due to small sample size observations from 
Luxembourg and the U.K. should be excluded. Then, the lowest share of innovating fmns 
is observed for Italy with 47.7 percent, which is probably due to the large sample size (791 
. fmns, that is 40.8 percent of the whole sample) and the dominance of 347 small fmns with 
5 to 49 employees. 53 The next lowest share of 62.6 percent product innovators we find in 
France. The largest share of innovators we fmd for Denmark (89.7 percent) and Gennany 
(89.9 percent). 
52 The oth"'er pertinant information regarding R&D strategies and technological co-operation was already 
analyzed in Chapter 5. 
53 But Italy has -- according to our defmition of a product innovator -- the highest share of product innovators 
in the sample, that is. 50.2 percent (see second last column in Table 6.13). 
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Table 6.13 Descriptive Statistics for Innovation, R&D, and Investment by Country and Segment of .Industry 
(Unweighted mean values and shares) 
Share of Total S.alc:s Share of all Firms 
Innovation R&D Investment Product Process Innovation R&l> 1992 
' 
Intensity lmensity Intensity Innovation Innovation Intended 1993-
1992 1992 95 
Country 
Belgium 4.19 3.37 2.71J HO.O 7M.8 76.3 ()().(, 
l>enniark 6.79 9.13 2.41 81J.7 H7.2 87.2 91.1 
France - - - 62.6 ft0.9 71.9 -
Oem1any 7.63 4.36 8.74 89 .. 9 KIJ.9 89.4 86.3 
Greece 6.45 5.10 0.62 (SS.IJ) (52.9) 52.9 85.7 
lrland 4.43 3.12 4.99 79.8 79.8 84.8 93.8 
Italy 3.64 3.()6 4.45 47.7 47.0 73.3 KU.8 
Luxembc~t~rg 1.17 0.92 0.38 (18.2) ( 18.2) 45.5 511.0 
Nl.'!therlands 3.01 3.71 15.76 81.4 81J.9 80.9 77.8 
Norway 4.42 3.90 8.95 85.0 85.0 95.5 94.1 
Portugal 1.85 2.37 0.26 (95.8) ( IOIJ.U) 97.9 66.7 
Spain 6.96 3.13 - li8.2 . 63.6 - tltU 
United Kingdom 10.03 4.27 4.32 (88.9) I K8.lJ) 77.8 100.0 
All Firms (Sample means) 4.78 3.64 6.19 64.6 63.6 77.2 R3.7 
Segment 
24.1 Basic Chemicals 3.74 2.56 4.30 63.5 63.5 77.8 R2.6 
24.2 Agrochcmicals 3.41 3.06 1.~8 66.7 61.1 77.8 H4.2 
24.3 Paints, Varnishes 3.06 3.01 3.85 56.3 55:3 74.5 K7.8 
24.4 Phannaceuticuls 6.05 s.m 4.19 64.1 63.3 19.4 RIJ.7 
24.5 Soup, Detergents 4.56 2.41J .\.53 56.9 . 56.4 7l.li U1.8 
24.6 other Chemical Products 3.59 3.13 3.62 68.0 67.2 78.0 78.0 
24.7 Man-Made Fibres 3.16 2.19 6.59 56.6 56.6 71.7 92.6 
Firm Size (Employees) 
5-49 4.65 3.52 5.15 47.9 46.8 69.8 69.8 
50-249 3.61 3.12 3.50 66.7 66.1 76.3 84.6 
250-499 2.90 2.70 2.30 78.2 16.9 84.7 91.0 
500-999 6.68 4.23 3.92 86.8 85.3 89.8 93.8 
1000 and more 5.05 6.08 3.40 95.3 94.5 95.9 99.0 
--------------------
R&D Planned Proouct 
next 3 y eurs Innovators 
93.8 31.0 
82.9 29.4 
- -
91.9 44.6 
- -
93.8 37.3 
83.2 50.2 
50.0 -
66.7 37.9 
94.1 43.8 
4.2 37.5 
93.2 -
100.0 50.0 
81.0 56.9 
87.1 30.8 
89.5 62.5 
88.9 65.8 
87.7 46.7 
78.9 52.1 
73.6 43.5 
92.6 16.0 
72.7 45.7 
79.8 43.5 
88.7 42.5 
85.1 40.5 
95.9 40.7 
Note: 'l11e following countries are included in the analysis by segment of industry: Belgium, France, Gcm1any, Ireland, Italy, Luxembourg, Netherlands, Norway, United Kingdom. 
'l11e intensities are computed for the innovating firms reporting either innovations and/or R&D activity. 
In case of R&D there arc 931 innovating fim1s and 1007 non-innivators ("missing values"). The observations for about one percent of the 
innovating li1ms are excluded from the analysis. ll1esc outliers arc defined as intensities above 50 percent. 
Process 
Innovators 
58.6 
38.2 
-
46.8 
-
53.3 
50.5. 
-
59.3 
43.8 
0 
-
37.5 
50.6 
I 
65.4 
37.5 
32.9 
47.3 
46.6 
52.0 
. 80.0 
49.1 
49.0 
46.7 
49.4 . 
53.8 
-- ·- ·--
Table 6.13a Distribution of Sales Shares According to the Stages of the Product Life 
Cycle (Unweighted mean shares in percent) 
Share of Total Sales 
Stages of the Product Life Cycle 
No. of 
Countrv Introduction Growth Maturitv Decline Observations 
Belgium 8 11 26 55 64 
Denmark 10 17 30 43 35 
France 
- - - - -
Germany 13 15 25 47 120 
Greece 5 17 27 . 51 21 
Ireland 10 11 29 49 80 
Italy 8 10 23 59 380 
Lu:"<embourg 3 14 36 48 2 
Netherlands 9 16 22 54 180 
Norway 11 13 21 55 17 
-Portugal 
- - - - -
Spain I 
- - - - -
United Kingdom 8 14 19 59 8 
All Firms (Sample means) 
Se210ent 
24.1 Basic Chemicals 9 11 23 57 210 
24.2 Agrochemicals 12 14 20 55 19 
24.3 Paints, Varnishes . 9 10 22 58 82 
24.4 Pharmaceuticals 11 12 29 48 199 
24.5 Soap·and Detergents 10 10 24 56 86 
24.6 other Chemical PrOducts 9 13 21 57 221 
24.7 Man-Made Fibres . 8 10 29 53 27 
Finn Size (Emplovees) 
5-49 9 9 23 58 :..!H 
50-249 10 12 23 54 400 
I 
250-499 10 12 27 51 128 
500-999 9 12 26 53 82 
1000 and more 9 13 25 53 91 
Note: This table is not discussed in the report. 
74a 
ll 
.. 
I I 
.I 
l 
! 
i ' 
I 
. 
I I 
Figure 6.1 show the observed average share for innovators. The left bar exhibits the share 
of firms which introduced product innovations in the period 1990-1992. Only half of the 
small firms with S to 49 employees report to have developed an innovaton. The share of 
innovators increases significantly up to 68 percent with fmns having SO to 499 employees. 
Then the share converges to about 95 p~rcent innovators in the group of fmns with 1000 
employees and more, and, the largest fmns are .all innovators. 
A different picture emerges when analysing the distribution of innovating fmns by segment 
of industry. The variation among the segments is quite small. The size effect is somehow 
equalized when applying a distribution according to segments of industry. The highest 
shares are with agrochemicals and with other chemical products. 
Whether innovative activities are planned the next three years is shown as third bar 
(,,Innovation Intended 1993-1995) in the figure. This share is for some countries lower than 
the actual value and for some greater as shown in Table 6.13. Significantly more 
innovations are to be expected for Italy (plus 25.6 percent), France (plus ll percent), and 
Norway (plus 10 percent). · 
6.3.2.2 Innovation Expenditures 
The innovation expenditures measured in the CIS are a result of the various stages of the 
product innovation process. According to the CIS the total amount of expenditures on 
innovative activity ought to be attributed to the following activities: R&D; acquisition of 
patents and licenses; product design; trial production, training and tooling-up; market 
analysis (excluding launch costs) and other activities. This measurement is based on the 
new defmition in the OSLO-Manual (OECD 1992). Previous work used a more narrow 
defmition focusing on applied reseach arid development expenditures. The CIS data allows 
to single out the importance of the various expenditure items. 
The analysis of R&D effort plays a crucial role in economic analysis. 54 The frrst hypothesis 
in these studies is that more important innovations require on average a larger share of 
innovation costs for R&D. A second hypothesis says, that large fmns devote a larger 
percentage of total innovation cost to R&D than smaller firms. And thirdly, it is assumed 
the more experienced fmns are with R&D the higher the likelihood that they learn and 
become more efficient, and thus would use a smaller share of innovation expenditures for 
R&D to innovate. 
The overall picture is shown in Figure 6.2. This figure allows to compare intensities of 
innovation, R&D, and investment (that is their expenditures as~ share of total sales). The 
innovation intensity is highest for fmns of the size 500 to 999 employees and - - among 
-
54 See for an overview of empirical research on R&D Cohen and Levin (1989) and for detailed analysis of 
the distributions of R&D expenditures in various- industries·Cohen and Klepper(****), in: AER. 
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Figure 6.1 Innovating and .R&D Performing Firms as Share of all Chemi!=al Firms in 1992 
in 13 European .Countries 
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others for fmns with 1000 employees and more -- the innovation intensity is lower. 
Regarding R&D intensities this pattern is reversed. That is, the R&D intensity· of the largest 
ftnns is highest Structural differences with respect of segments of industry become clear 
from Figure 6.3. The similarity in the pattern ,,innovation-R&D-investment intensity" of 
the segments agrochemicals and pharmaceuticals is obvious but the magnitude is different. 
The R&D intensity of the pharmaceutical industry is twice as large as the one for 
agrochemicals. As expected, the investment intensity of the manufacturers of man-made 
fibres is the highest in the whole industry and 50 percent higher than the one of the 
pharmaceutical segment. 
How the particular components of innovation expenditures vary according to firm sizes is 
shown in Figure 6.4. Again ·the R&D share of innovation expenditures increases with 
inceasing fmn size. It is nearly twice as large for the largest fmns as compared with the 
smallest firms. But, for the small fmns the share ,other innovation expenditures" is about 
18 percent which in part might also be devoted to R&D activities of these fmns. 
Figure 6.5 provides a comparison. of the structure of innovation expenditures accordmg to 
the segments of the chemical industry. The highest R&D share are with agrochemicals and 
paints and varnishes. There are also considerable differences in the shares of product 
design costs and costs for trial production, training and tooling-up. 
6.3.3 Comparison of Innovative Performance 
The CIS does not in~lude any particular measure of innovative through-put like the 
number of patents applied for or the stock of patents. Neither it does include information 
on the number of new products introduced into the market nor is infonnation on any 
profitability measure reported. As a result this study has to focus on innovative outputs of 
incrementally ·and radically chapged products, and sales flowing from these products. In 
particular, responses to Question 15a (How were the enterprise's total sales distributed 
across these types of products? ( 1) Products which essentially have remained 
technologically urzchanged during 1990-1992; (2) products subject to inc;·emental 
technological changes ·in 1990-92; and (3) significantly changed from a technological 
viewpoint or newly introduced products during 1990-92). These ~sponses will be used 
alternatively as a continuous variable, bounded by zero and one, and as a binary variable 
(zero if the enterprise is not innovative and one if it is innovative) in a logit analysis . 
\ 
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Figure 6.2 
5-49 
Innovation Intensity, R&D Intensity and Investment Intensity by Firm Size 
for Chemical Firms in 13 European Countries 
50-249 250-499 
Employees 
500-999 1 000 and more 
Note: Observations with intensities greater than 50 Percent are excluded from the computation 
of the averages in the figure. 
Figure 6.3 Innovation Intensity, R&D lnte.nsity and Investment Intensity by Segments of the 
European Chemical Industry for 8 Countries 
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Note: The following countries are include in the analysis: Belgium. Germany, Ireland, Italy, Lu~embourg. the Netherlands, 
Norway, and the United Kingdom. 
Observations with intensities grather than SO Percent are excluded from the computation of the averages in the figure . 
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Figure 6.4 Components of Innovation Expenditures by Firm Size for Chemical Firms 
in 13 European Countries 
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' Figure 6.5 Components of Innovation Expenditures by Segments of the Chemical Industry 
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6.3.3.1 Estimation of Elasticities of Innovative Output 
This part of the analysis leads directly to the ,Schumpeterian Hypothesis", a classic issue 
of public policy which has centered on the size of innovating firms. Because of assumed 
scale economies for R&D inputs in producing innovative output, it has been hypothesized 
that large fmns have an inherent advantage in innovative activity. As Scherer (1983, pp. 
234-5) reports, the empirical evidence sugges.ts that , .. .- size is conducive to vigorous 
conduct of R&D." However, as Fisher and Temin (1979) and later Kohn and Scott (1982) 
demonstrated, the determination of an elasticity of R&D inputs with respect to frrm size 
exceeding unity does not necessarily imply that scale economies exist for R&D in 
producirtg innovative output This became clear in the work by Acs and Audretsch (1987; 
1988; and 1990) who found that small fums can be at least as innovative as their larger 
counterparts in certain industries. Although their analyses were undertaken at the aggregate 
industry level, the results cast some doubts on the virtually untested but central proposition 
that scale economies exist for R&D in .generating innovative activity. 
R&D and Innovation The purpose of this part of the study is to apply the CIS measure 
of innovative sales output at the firm level to determine whether scale economies do exists 
for R&D inputs in the European chemical industry. It is conceivable that the quality or 
significance of innovations is not constant across either fmn size or with respect to R&D 
~ffort However, using two . measures of innovative output55 and a quite large and 
homogeneous sample of fmns, these measurement issues will be ruled out. 
As a frrst approximation ·to answering the question whether scale economies exist for R&D 
in producing innovative output in the chemical industry, a simple production function 
relationship of the type used by Bound et al. (1984) can be examined: 
NPS =aRDI31 
where NPS is the sales due to significantly changed products or introduced in 1990-1992 
(,,new product sales") and RD is the fmn's expenditure on R&D. For the linear regression 
the logarithmic values56 are used, that is 
ln NPS = ln a+ ~ 1 ln RD with the estimated coefficients for the whole sample: 
ln NPS = 4.01 + 0.64ln RD 
(25.78) (27.25) 
F=742.73 N=760 
55 These measures are ( 1) the sales share of significantly changed products and (2) the sales share of 
incrementally and significantly change products. 
56 We use the natural logarithm On) where as Bound et al. (1984) apply the logarithm at basis 10 (lg). They 
are equivalent, that·is, 1n N = 2.302591g N. For the estimation of the regression equation this implies that 
the constant term of the In-equation is 2.3 ~es the constant of the lg-equation. 
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where the t-values are listed in parenthesis. The estimated elasticities of new product sales 
with respect to R&D expenditures by country for the chemical and pharmaceutical industry 
are listed. in Table 6.14.-These elasticities are the elasticities at the sample mean of NPS 
and RD. The estimation for Denmark is not signif!.cant. For the other countries the 
elasti~ity ranges from 0.39 for Portugal to 0.79 for Ireland. These values are some what 
different from the elasticities between 0.32 and 0.38 for R&D and patents· based on 2582 
fmns estimated by Bound et al. (1984). 
The range of elasticities for the various segments of the industry is smaller (see Table 
6.15). The values range from 0.49 for. man-made fibres to paints and varnishes 0.73, that is, 
1 ECU spend for R&D in paints and varnishes results in new product sales. of 0.73 ECU. 
Two considerations should be mentioned· when discussing these elasticities. First, there is 
an estimation effe.ct due to the homogeneity of the sub-samples. As Table 6.16 shows the 
values are lower and the range of coefficients is much smaller when the elasticities are 
estimated acc~rding to fmn size groups. The values range for the whole chemical and 
pharmaceutical industry from 0.23 to 0.32. The size effect has an impact on the 
estimations, that is, the broader the size range the steeper the slope of the estimated 
relationship and the higher t;he estimated elasticity because the sums of R&D spend by 
larger fmn are much higher than those_ of small fmns. A second consideration is based on 
spillover effects. One could argue -- in case spillover effects are ·observed in the whole 
industry -- that the most reasonable estimation of elasticities is for the whole industry. This 
estimation then would capture the spillover effects. On the other hand. the estimations for 
more homogeneous groups are lacking spillover and their elasticities as such are 
significantly lower. Which, in fact, is observed. 
Firm Size and Innovation As Baldwin and Scott (1987) confmn in their review of the 
literature, there has already been a plethora of studies examining the relationship between 
fmn size and R&D effort.S7 Although the work by Bound et al .. (1984) indicates that 
expenditures on R&D increase proportionately with fmn sales, and Soete (1979) found that 
R&D increases more than proportionately with fmn sales, virtually no one has found that 
this relationship is anything less than proportional: However, just as there have only been a 
handful of studies examining the relationship between innovative outputs and inputs, the 
lack of meaningful data has not enabled researchers to estimate the relationship between 
fmn size and innovative output. Thus, it remains to be empirically answered: To what 
extent does innovative activity increase or decrease along with fmn size? 
57 See Cohen and Klepper ( 1992) for a recent review and analysis of R&D intensities in the U.S .. industry. 
Si · 
Table 6.14 Estimated Elasticities of Innovative Output (New Product Sales) with 
Respect to R&D Expenditures by Country for the Chemical and 
Pharmaceutical Industry. 
Country R&D Elasticity R2 Significance Number ofFirms 
(p values) 
Belgium 0.64 0.42 0.0000 48 
Denmark 0,24 0.05 n.s. 30 
Germany 0.75 0.59 0.0000 115 
Ireland 0.79 0.50 0.0000 60 
. 
Italy 0.58 0.48 0.0000 251 
Netherlands 0.61 0.50 0.0000 121 
Norway 0.45 0.58 0.0024 12 
Portugal 0.39 0.15 0.0333 "24 
I 
Spain 0.69 0.39 0.0000 92 
United Kingdom 0.69 0.68 0 . .0145 7 
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Table 6.15 Estimated Elasticities of Innovative Output (New Product Sales) with 
Respect to R&D Expenditures by Segment of Industry 
Industry. Segment R&D Elasticity R2 Significance Number of 
(NACE) (p values) 
Basic Chemicals (24.1) 0.62 0.49 0.0000 
Agrochemicals (24.2) 0.43 0.05 n.s. 
Paints, Varnishes (24.3) 0.73 0.53 .o.oooo 
Pharmaceuticals (24.4.) 0.68 0.61 0.0000 
Soap and Detergents (24.5) 0.66 0.37 0.0000 
Other Chemical Products (24.6) 0.74 0.54 0.0000 
Man-Made Fibres (24. 7) 0.49 0.26 0.0102 
Note: The 8-country sample includes Belgium, Germany, Ireiand, Italy, Luxembourg, the 
Netherlands, Norway, and the United Kingdom. 
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Firms 
143 
11 
63 
150 
61 
159 
21 
Table 6.16 · Estimated Elasticities of Innovative Ot,atput (New Product Sales) with 
Respect to R&D Expenditures by Size Group for the Chemical and 
Pharmaceutical Industry 
Size Group R&D Elasticity R2 Significance Number afFirms 
(Employees) (p values) 
s -49 0.30 0.10 0.0000 162 
50-249 0.32' 0.11 0.0000 329 
250-499 0.11 0.01 n.s. 113 
soo·- 999 0.23 0.14 0.0007 72 
1000+ 0.31 0.12 0.0007 83 
Note: The 8-country sample includes Belgium, Germany, Ireland, Italy, Luxembourg, the 
Netherlands, Norway, and the United Kingdom. 
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We agai,n follow the example of Bound et al. (1984)58 in providing a fJISt approximation of 
the relationship between finn size, measured by ECU thousands of sales (SAL), and the 
innovative output measured as new product sales. The estimated function for the whole 
sample of firms from the chemical and pharmaceutical industry then is: 
. . 
In NPS = - 1.51 + 0.94 In SAL 
(-9.10) (57.96) 
R2 =0.77 
F =3359.22 
N= 1027 · 
The elasticity of innovative output with respect to finn size (measured in ECU) is at the 
.sample mean 0.94, that is less than unity, implying that innovative activity does not 
increase proportionately along with fmn · size. A different result emerges when an 
alternative measure of fmn size, employment (EMP) is substituted for sales: 
In NPS = 2.97 + 1.00 In EMP 
(24.85) (43.45) 
R2 =0.65 
F = 1887.89 
N= 1027 
That is, the elasticicy of innovative output with respect to fmn size (measured in 
employees) is at the sample mean 1.00, that is unity, implying that innovative activity does 
increase proportionately along with fmn size. 
Table 6.17 shows the estimated elasticities of innovative output wit,h respect to fmn size by 
country and by segment of industry. Much lower than unity are the values for Portugal with 
0.69 for size in employees and 0.63 in sales. The innovative output incre~es significantly 
with employment in Ireland with 1.45. For the other countries it reasonable to assulne that 
innovative activity does' increase proportionately along with fmn size. 
With respect to industry segments a less than proportionate increase with size is observed 
for the manufacture of basic chemicals. This is plausible due to the limited opportunities. 
On tl1e other hand we fmd a more than proportionate increase with size meas~d in 
employees f'?r the agrochemical segment which is also reasonable on the same grounds but 
with an opposite sign, that is, agrochemicals are confronted with an increasing number of 
opportunities to innovate when fmn size increases. 
6.3.3.2 Estimation of Returns to R&D 
Further insights witlt respect to the returns of R&D might be achieved the es~ation of a 
linear ana quadratic relationship. Some authors use an additional cubic tenn. For statistical 
reasons, but also due to problems to be expected with the interpretation of the estimated 
coefficients, we have not used a cubic term. The correlation we found between the 
quadratic and cubic R&D tenn was higher than 0.9. Using the cubic tenn would have led 
58 See also Schwartzman (1976) for an estimation of elasticities for the pharmaceutical industry. His equation 
includes also the term (In size)2 which allows to derive the elasticity for the whole range of sizes. 
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Table 6.17 Estimated Elasticities of Innovative Output (New Product Sales) with 
Respect for Firm Size by Country and by Segment of Industry 
Country1> Size Elasticity R2 R2 N ' I , 
,"'! 
Employees Sales emp sal 
Belgium 0.92 0.92 0.56 0.72 49 .. 
Denmark 0.89 0.96 0.60 0.75' 31 
France 1.03 0.97 0.68 0.79 147 
Germany 1.01. 0.88 0.75 0.84 129 
Ireland 1.45 1.21 0.64 0.77 63 
Italy 0.96 0.96 0.61 0.76 302 
Netherland 1.03 O.'t7 0.60 0.70 147 
N~rway 0.93 0.78 0.88 0.85 12 
Portugal 0.63 0.69 0.39 0.65" 37 
Spain 1.02 0.97 0.55 0.67 103 
United Kingdom 1.12 1.06 0.85 0.93 7 
Industry Segment (NACE)2> 
Chemical Industry (24) 1.00 0.94 0.65 0.77 1027 
Basic Chemicals (24.1) 0.88 0.86 0.60 0.77 200 
Agrochemicals {24.2) 1.27 1.02 0.73 0.78 17 
Paints, Varnishes (24.3) 1.13 0.97 0.70 0.73 97 
Pharmaceuticals (24.4.) 0.99 0.94 0.64 0.74 206 
Soap and Detergents (24.5) 1.02 0.98 0.66 0.83 96 
Other Chemical Products (24.6) 1.03 0.99 0.69 0.78 . 208 !! 
Man-Made Fibres {24. 7) 1.17 0.98 0.71 0.73 26 
' i 
! ""' 
Note: 1> All coefficients are significant at p < 0.0001, except the one for the U.K. with 
p=0.002. 
2
> All coefficients are significant at p < 0.0001. i 
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us into problems of autocorrelation. The interpretation of the cubic term would require ~o 
check each individual function for turning point. For these two reason we have estimated 
· the following model: 
NPS = a + b RD + c RD2 • 
For the dependent variable we used only one measures of innovative output, that is the one 
for significant product .innovations. In case we would have used the sum of sales due to 
incremental and significant product innovations there is less discrimination between 
innovators and non-innovators. Tabl~ 6.18 shows the estimated coefficients for the 
countries and their chemical industry as a whole, including pharmaceutical fmns. Based on 
the type of returns to scale of R&D observect we can distinguish three groups of countries: 
those with decreasing returns to scale in R&D (positive coefficient of the linear tenn and · . 
negative coefficient of the quadratic term), those with increasing returns to scale in R&D 
(positive coefficient of the linear term and positive coefficient of the quadratic term}, and a 
group for which we have no conclusive evidence. 
We fmd decreasing returns to scale for Italy, the Netherlands, Spain, Ireland, and Norway. 
For 134 fmns in the German sample there is evidence for increasing returns to scale in 
R&D. No conclusive evidence we find for Belgium, Denmark, and Portugal. 
Table 6.19 shows the returns to scale in R&D for the segments of the chemical industry. 
We fmd no conclusive evidence for the manufaCture of man-made fibres and for 
agrochemicals. The returns for all other segments are decreasing . 
. 
The result of increasing returns to R&D for Germany is surprising. Surprising with respect 
to results reported in the literature and compared to the other countries. Except this one 
country there is no evidence that increasing returns to R&D expenditures in producing 
innovative output exist. Rather, our empirical results for the European chemical industry 
suggest, with the one exception, diminishing returns to R&D are the rule. Thus, while 
larger fmns are· observed to undertake. a geater effort towards R&D, each additional ECU 
of R&D is found to ·yield less in terms of innovative output Therefore it is reasonabel 
tocheck whether we can find differences which distinguish innovators and non-innovators 
in our sample. 
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Table 6.19 Industry-Specific Regressions for Innovative Product Sales (for Major Innovations) 
and R&D in 1992 
(in thousoand ECU; statistics in parentheses and significance in squares; 
R&D Intensities greater than 30 percent are excluded) 
Industry RD RD2 Constant R2 
Decreasing Returns 
24 Chemical Industry 3.945 
-1.069*1o-6 4799.603 0.618 
(without (13.666) (-3.266) (0.974) 
Pharmaceuticals) [0.0000] [0.0012] [0.3307] 
24.1 Basic Chemicals 13.536 
-4.767*1o-5 -20946.5 0.443 
(10.524) (-8.310) (-1.619) 
[0.0000] [0.0000] [0.1072] 
24.3 Paints, Varnishes and 11.319 
-1.515*lo-4 -2766.9 0.501 
Similar Coatings (6.288) (-5.132) (-1.099) 
[0.0000] ,[0.0000] [0.2752] 
24.4 Pharmaceuticals 1.602 
-5.78*lo-6 ° 4648.2 0.363 
(9.481) (-6.910) (2.123) 
[0.0000] [0.0000] [0.0352] 
24.5 Soap and Detergents 10.192 
-3.856*1o-4 6346.2 0.125 
(1.163) (-0.582) (1.074) 
[0.2490] [0.5625] [0.2867] 
24.60 Other Chemical 4.659 
-1.731*1o-6 769.2 0.966 
Products (20.104) (-7.168) (0.235) 
[0.0000] [0.0000] [0.8142] 
No conclusive Evidence 
24.2 Agrochemicals 0.492 
-3.956*1o-4 1842.2 -0.111 
(0.180) (-0.401) (-0.613) 
[n.s.] [n.s.] [n.s:] 
24.7 Man-Made Fibres 3.255 3.191*1o-5 6505.4 0.228 
(0.773) (0.064) (1.495) 
[0.4718] [0.9494] [0.1498] 
Note: The following countries are include in the analysis: Belgium, Germany, Ireland, Italy, the 
Netherlands, and Norway. 
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F n 
444.271 548 
[0.0000] 
72.940 182 
[0.0000] 
39.634 78 
[0.0000] 
51.490 178 
[0.0000] 
0 6.066 72 
[0.0037] 
2541.039 177 
[0.0000] 
0.251 15 
[0.7816] 
4.411 24 
[0.0251] 
6.3.3.3 A Logit Model of Innovation 
The pace of innovation in the European chemical industry has been truely remarkable. An 
important question is whether such a development will continue and what factors have 
affected such innovative behavior. That is, in particular, how can a fum in a scientifically 
and technologically based industry build and maintain its capabilities? In view of the fact 
that the CIS data provides no information on individual innovations in this section we will 
neverthele~ examine the relationship between important characteristics of fmns of the 
chemical industry and their innovative behavior. Obviously this can only be done in 
recognition of the limitations of survey data available in the CIS. . 
Although this is not the place for a critical examination of the literature on innovation and 
R&D in the chemical industry we should mention two frequently cited studies which relate 
to the innovative behavior of Du Pont, the largest US-manufacturer in the chemical 
industry.S9 These are the studies by Mueller and by Hollander. Mueller analysed 25 of Du 
Pont's most important product and process innovations made between 1920 and 1950 and 
which accounted for about 45 percent of the company's sales. Mueller found that of 18 new 
products only five could be credited to Du Pont and another as the co-inventor. The Du 
Pont record for process innovations was five out of seven. Mueller's conclusion is 
important because it sheds light on the ~conomics of innovation in large chemical fmns --
not only to Du Pont -- but also with some qualificatio!lS to the nine large European funs we 
have analysed in the fl.I'St part of this report. Mueller concluded: 
,Du Pont has been more successful in. making product and process improvements 
than in discovering new products. Except for nylon, [O]rlon, and neoprene, Du 
Pont's major product innovations have ~een based upon technology acquired from 
others. Next to be considered is the significance of these fmdings in relation to· the 
frequent statement that Du Pont's bigness has created a perfect environment for 
inventive activity resulting in important new products and processes. The record· 
during the period of this study does not support such a generalization. Although Du 
Pont has expanded its research expenditures as it has grown - from slightly· nnder $1 
million annually shortly before 1920 to $38 million in 1950 - there has not been a 
proportional acceleration in the number of important inventions (as defmed herein) 
coming from its laboratories. Nylon still re~ains its greatest success story. Neoprene, 
discovered in 1931 [sic], probably has been exceeded only by nylon and [O]rlon; and 
the latter was an outgrowth of its basic discoveries underlying nylon".60 
S91bese studies are Mueller, W.F. (1962), The Origins of the Basic Inventions Underlying DuPont's Major 
Product and Process Innovations, 1920-1950, and Hollander, S. ( 1965), The Sources of Increased Efficiency: 
A Study of Du Ponts Rayon Plants. Our presentation of the Du Pont case study draws on the publication by 
Hounshell (1995). · · 
60 Mueller, p. 346, quoted according to Hounshell ( 1995), p. 176 
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In line with this conclusion Mueller raised the issue about incentives for basic research. He 
agreed- with Richard Nel$on's 1959 thesis that ,though private profit motives may 
stimulate the fmns of private industry to spend an amount on applied research reasonable 
close to the figure that is socially desirable, it is clear[ ... ] that the social benefits of basic 
research are not adequately reflected in opportunities for private profit, given our present 
economic structure".6t 
A provoking result was put foreward by Hollander (1965). While looking for the sources of 
increased efficiency of productivity in Du Pont's manufacturer of rayon he found that 
minor and almost routine improvements added up to significantly greater gains in 
productivity than did process improvements deriving from Du Pont's rayon research and 
development laboratories. -Hollander's conclusion was that industrial R&D did not 
contribute as much to technological change within Du Pont as some people had thought. .If 
there were benefits deriving from basic R&D, they were not being appropriated by DuPont 
but were becoming public property through such routes as conference presentations and 
publications. 
According to Hounshell (1995)'these studies were strongly colored by the context of that 
time, that is, they argued for massive funding of basic research. They are, nevertheless, 
interesting because they shed some light on the uncertainties involved. Furthermore,. recent 
theoretical research· has developed a better understanding of the economics involved in 
process and product innovations and in the economics of research joint ventures .. For 
example,. Rosenkranz (1996)62 studied individual and cooperative R&D decisions as an 
example of feedb~k processes of market structure and fmn behavior. This is important 
because today fmns are more and more decfding to coordinate their R&D activities with 
their most potential rivals. Furthennore, in Europe and in the USA, anti-trust authorities 
tend to treat these cooperative increasingly favorably and it is also being discussed whether 
to extend this fa:vorable treatment to. R&D agreements which also provide for joint 
exploitation of the results. But, there is still little empirical evidence and theoretical 
knowledge on these relationship~ regarding the chemical industry. 
Of similar interest for the purpose of our study is theoretical work by Rosenkranz (1995) 
on the simultaneous choice of process and product innovation. 63 She shows how the 
optimal division between these two kinds of R&D activities changes with market size. The 
higher consumers' willingness to pay, the more fmns' investment is driven to product 
innovation. If fmns coordinate their R&D· activities and share R&D costs but remain rivals 
in the product market, they will reduce costs and intensify product .innovation more than 
61 Mueller, p. 346, quoting Nelson, R.R., The Simple Economics of Basic Scientific Research -A Theoretical 
Analysis, iJ.t: Journal of Political Economy, 1959, pp. 297-306; quoted according to Hounshell (1995), p. 176 
62 Rosenkranz, S. (1996), Product Innovation and Cooperation, Berlin: Edition Sigma 
63 Rosenkranz; S. ( 1995), Simultaneous Choice of Process and Product Innovation, Discussion Paper FS IV 
95-30, Wissenschaftszentrum Berlin. 
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under R&D competition. The optimal proportion of R&D investment is driven more to 
product innovation than under R&D competition. A further result of the game-theoretic 
analysis by Rosenkanz is, that welfare is increased if fmns coordinate· their research ~ I 
activities and share R&D costs. When firms cooperate but do not share their R&D costs, 
welfare is only enhanced if product innovations are not too expensive. 
The foregoing discussion suggests that is important also for fmns in the European chemical 
industry to explore the possibilities of coordinating dleir research effort and if it is possible 
to share R&D costs. Furthermore a fmn's strategy formulation determines how the fmn 
allocates its R&D budget to product and process innovation activities. Here is not the place 
to provide further details on these issues, but attention should be given to studies which 
discuss the relative importance of characteristics of fmns in promoting technological 
innovations.64 We have to answer the question in what kinds. of fmns and under what 
conditions are product and proceSs innovations are undertaken? What are the 
characteristics of the fmns that are expected to affect strategy formulation of the finn and 1 
thereby determine its innovative behavior? For that purpose we will use a simple logit 
regression model to estimate the likelikhood that a fmn is a product innovator or a process 
innovator respectively. 
The Variables and Analysis The dependent variable distinguishes the firms on the 
basis of their innovative sales. A fmn is defmed as a product innovator, that is the variable 
is 1, when the share of total sales due to incrementally changed and significantly changed 
products is 30 percent and more and equal to 0 when the share. is less than 30 percent. 
The fmn is defmed as ·being a process innovator, that is the dependent variable is 1, when 
the percentage of total R&D expenditures allocated to process innovation is 25 percent and 
more. If the share of these expenditures is less than 25 percent the variable is equal to 0. 
Five independent variables are used to determine whethex: a fmn is a product innovator or 
not The frrst variable is ~e perceived importance of an objective of innovation, that is, the 
importance which is attributed to improve product quality by means of innovation activity. 
The second variable measures the commitment towards competition. That is, if a finn 
regards it as important to have a lead time advantage over competitors in order to main~n 
or increase product ilinovation it is regarded as being committed to innovation competition. 
The third variable measures the perceived risk of a strategy of-product innovation. For that 
purpose a measue of the barriers to innovation is used, namely the role of excessive 
perceived risk related to a product innovation. 
To determine what might characterize best the process innovator we assumed that this 
would ~ a very strong orientation towards competition. We expected something which 
64 See e.g. for a detailed analysis of these issues Albach ( 1994 ). 
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would have to do with price-volume competion since this can only be achieved via process 
innovations. The most appropriate variable to proxy this frem the CI~ data base is the 
inclination to create new -markets in Japan. We would expect this to be an important 
characteristic of a process innovator since that is a domain of the Japanese and other Asian 
rivals in global competion .. Furthermore, we ·expected an economical use of resouces as an 
important determinant of being a process innovator. For the chemical industry we thought 
it must be an important objective to reduce energy consumption. This seems to be a 
rational strategy in case the pay-off period {)f an innovation is expected to be too long to 
approach this via the use of a process innovation. That is, a relationship is assumed to exist 
between the attitude to regard a pay-off perioq as too long and the use of process 
innovation to compensate for this~ The riskiness towards the imitation of product 
innovations would reduce the likelihood of the use of process innovations, that is, in case 
the innovation is easy to copy, it is regarded as crucial for the fmn (to a lesser extent) to be 
a process innovator. 
To te$t for the impact of the resources commited to product and process innovation we 
include the innovative intensity. This is reasonable because it. measures the overall 
commitment of the fmn towards innovation, that is for product and for process innovation. 
A simllar argument can be made for the export intensity of a fmn. A fmn is more 
commited to innovation and therefore to competition the higher the export intensity is. 
Export intensity is measured as· exports dived by sales in percent. 
. The results of the models are in Table 6.20. The product innovator model provides a strong 
support for the vie~ that a commitment to product innovations and the awareness of the 
risks related to it increases the likelihood of being a successful product innovator. It is in 
particular the commitment to improve product quality that increases the probability .of 
being a successful product innovator. The innovation intensity is not significant and neither 
is the export intensity as measured by the export share. 
The process innovator model provides support for the view that emphasis on competition 
and to compete with .rivals in their own arena as well as a commitment to the economical 
use of resources increases the probability of being a process innovator. In case product 
innovations are easy to copy the probability for process innovation decreases. While the 
innovation intensity is not significant, the export intensicy is. That is, the more a fi_rm 
pursues an export strategy the higher the likelihood of being a process innovator. 
The two equations are different in character. This has to do with differences in the 
properties of each particular type of innovation. The patterns found here imply that models 
of innovation strategy would do have to make a clear distinction between product and 
process innovation but to stress the importance of uncertainty related tb innovation as well 
as a clear focus on competition. However, the CIS data are too crude to be definitive on 
this point, and further theoretical and empirical work on innovation processes in the 
chemical industry is appropriate. · · 
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Table 6.20 Logit Regression Estimates for Product and Process Innovators in the European 
Chemical and Pharmaceutical Industry 
Variable 
Improving product quality 
(objective of innovation, v5_17) 
Effectiveness of having lead time over 
competitors 
(effectiveness of methods, v9a_5) 
Excessive perceived risk 
(innovation barrier, vl2_1) 
Creating new markets: in Japan 
(objective of innovation, v5_8) 
Reducing energy consumption 
(objective of innovation, v5_13) 
Pay-off period of innovation too long 
(innovation barrier, v 12 _ 4) 
Innovation too easy to copy 
(innovation barrier, vl2_15) 
Innovation intensity 
Export Share (as pet of sales) 
Constant 
-2 (102 likelihood) 
... 
Percentage correctly c1assitied 
N 
Type of Innovator 
PRODUCTINNOVATOR PROCESSINNOVATOR 
0.466 
(0.000) 
0.159 
. (0.052) 
0.140 
(0.091) 
0.007 
(0.330) 
0.151 
(0.570) 
-2.933 
(0 .. 000) 
721.54 
(0.000) 
62.6 
545 
0.247 
(0.005) 
0.309 
(0.000) 
0.120 
(0.091) 
-2.890 
(0.000) 
0.006 
(0.312) 
0.394 
(0.097) 
0.685 
(0.000) 
1007.79 
(0.000) 
61.3 
762 
Note: The table reports logit regressions. Numbers in parentheses are p. values. 
The dependent variables are defined ris follows: PRODUCT INNOVATOR is equal to 1 when th~ share 
of total sales due to incrementally changed and significantly changed products is 30 percent and more 
and equal to 0 when the share was less than 30 percent <CIS question 15a....2 and 15a_3). 
PROCESS INNOVATOR is equal to 1 when the percentage of total R&D expenditure allocated 
to process innovation is 25 percent and higher (CIS question l0c_2) and equal 0 when the share 
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7 Conclusion and Recommendations 
Conclusion This study has focused on the identification of innovative trends within the 
chemical industry between 1984 and 1993. Much of the information was gathered from the 
annual reports of nine major European chemical companies. Furthennore data from the 
Community Innovation Survey (CIS) was used to describe and explain the differences of 
innovative J.?erformance across finns within the European chemical industry. This novel 
methodological approach to combining two different data bases for the study of innovative 
behavior in the chemical industry seems to be very promising. 
The quantitative evaluation of said annual reports showed clearly discernible innovative 
trends, which conform with the findings of the pilot study .previously carried out. The 
categories of speciality chemicals, paints/varnishes and plastics were identified as the 
categories having shown the highest number of innovations during the course of the 
investigation period (1984 - 1993). 
The analysis of R&D input factors· and fmancial ratios for corporate success established a 
positive interdependence between R&D expenses and corporate success. An analysis of the 
individual categories, however, showed the strong dependence of R&D expenses on the 
respective corporate proftles. Since the companies' inclination to· report their innovations 
varied considerably, an evaluation of the innovative strength of the individual companies 
on the basis of their numbers of innovations was not possible. 
The overall plausibility of the results of the quantitative investigation proves that annual 
reports are indeed very suitable as a basis for such an investigation. The study was further 
able to confmn certain statements concerning various life cycle models. Life cycle models · 
rank among the few practice-orientated approaches with which innovative processes can be 
described. · · 
The qualitative investigation established similarities describing the momentary corporate 
and innovative strategies of Europe's chemical companies. Especially noticeable in this 
context was the attempt to increase the turnover share of highly refmed products. The 
strategies described in Chapter 5 are of special importance, since they are decisive for 
future innovative trends and, thus, for the future of the chemical industry in Europe. The 
CIS data base provided further evidence for the following trends: 
• 1. Increasing effort to apply strategies of cost leadership; in particular, for mass ,products 
such as basic chemicals. This takes place as restructuring within the basic chemical 
business and has concentrated on cost cuts. Since 1991 employment has been reduced 
by 255,000, a reduction of 14 percent. 
.. 
2. An increasing trend to specialize in certain product areas also has to do with Trend 1. 
For large firms, we could show an attempt to build up large market shares in relatively 
few products. The CIS data on the allocation of R&D. expenditures for product and 
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process innovation highlight the close interrelationship between the two corporate 
strategies: cost leadership and specialization. 
3. Almost all annual reports assign a central role to the concentration on key areas and/or 
key competencies, with a focus on the achievement of a strong market position and the 
concentration on areas with a high synergistic effect. 
4. Increasing activities towards strategic co-operation in the areas of production and R&D. 
This also because co-operation enables the fmns to enter into new markets, to shorten 
innovative periods, and to recognize technological potential at an earlier stage. The · 
results from the analysis of the annual reports are supported by the CIS data. Although, 
regarding the CIS data, we were not able to evalute the quality of the co-operative 
arrangement and had to relay simply on the numbers. 
5. A continuing trend towards globalization. The analysis of the annual reports suggests a 
significant level of globalization. The reports give a detailed account of regional 
developments (such as in Europe, North America, Latin America and Asia). One gets 
the impression that the large chemical fmns are of a really international character. Thus, 
they are able to compensate for a lack of opportunities within Europe by simply 
operating on an international level. The CIS provided support for the trend towards 
globalization, at least at the level of the European market. An interesting result is that 
for the creation of new markets within Europe a U-shaped relationship holds, that is, it 
is important for about 60 percent of the smaller and of the largest firms but not as 
important for the medium-sized fmns. 
The detailed analysis of the CIS 4ata base has shown a number of similarities and 
significant differences in the patterns of innovative behavior. We have analysed these 
patterns for countries, segments of the chemical industry and for different size classes of 
fmns. Finally, we provide two simple models of innovative behavior in the European 
chemical industry. 
The product innovator model provides a strong support for the view that a commitment to 
product innovations and the awareness of the risks related to it increases the likelihood of 
being a successful product innovator. It is in particular the commitment to improve product 
quality that increases the probability of being a successful product innovator. 1;'he 
innovation intensity is not significant and neither is the export intensity as measured by the 
export share. 
. . 
The process innovator model provides support for the view that emphasis on competition 
and to compete with rivals in their own arena as well as a commitment to the economical 
use of resources increases the probability of being a process iimovator. In case product 
innovations are easy to copy the probability for process innovation decreases. While the 
innovation intensity is not significant, the export intensity is. That is, the more a finn 
pursues an export strategy the higher the likelihood of being a process innovator. 
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Recommendations As far as we-can see there seems to be already agreement that the 
Green Paper on Innovation launched by the European Commission in December 1995 is a 
useful. basis for an effective discussion of policy implications. Therefore we will refer to 
the major problem regarding the chemical industry and we will cite a few other problems. 
The major problem needs obviously a solution at the national and European level if the 
concern of policy-makers is to keep employment and competitiveness of the European 
chemical industry at a high level. This problems is due to the unfavorable legal and 
regulatory environment as an _obstacle to innovation in the European chemical industry. It 
seem to be that the Green Paper on Innovation does not recognize this obstacle in an 
appropropriate fashion because it makes little use of the so-called ,,Molitor-Report" on the 
evidence of unfavorable legal and regulatory. Not only the climate for innovation needs to 
be improved but also the regularitory environment Therefore we think it is useful to 
mention a paper by the Association of the German Chemical Industry on the removal of 
obstacles to innovation. 65 This is in line with the argument Guilio Grata raised in Berlin 
that the discussion needs to come to earth and that ,we must now explore all these path and 
many more, and identify priorities".66 In this sense we are providing a brief summary of 
VCI-paper on the removal of obstacles to innovation. 
Some Considerations of the Chemical Industry The chemical industry indicates four 
reasons for innovative weaknesses in Europe: 
• laws and regulations cause excess regulation in all areas concerning R&D 
· • the existing state (tax) innovation incentives are too weak 
• the public policy of procurement aims minimally at innovative stimulation 
• there is not enough social acceptance of many R&D policies 
The task of the politician should be to overcome the above mentioned innovation obstacles 
step by step. 
Aspects to the excess regulation The EU guideline 67154Bn.Change . . guideline 
(Anderungsrichtlinie). is considered to be one of the greatest obstacles. Therefore t\le 
industry demands to release all substances serving only R&D from the compulsory 
registration and tests because the 100 Kg/year limit is not sufficient 
65 See VCI, Beseitigung von Innovationshemmnissen, Dokumentation, dated 20 June 1994. 
66 Gr~ G., Grata, Guilio c., Speech on the Green Paper on Innovation, Conference ,,Innovation", Berlin, 9 
-10 May 1996. 
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Additionally it is criticized that the draft of indication of quantity (Mengenschwellen-
konzept) admits no exposition view. That means that new materials from substance ·classes 
with known small toxic value have to pass the same test program as those with high toxic 
substance classes. 
The time limit of one year for introducing new material to use for produce-oriented R&D is 
often inadequete for the completition of producing. 
The EU guideline 9012i9, article 4 (1), Group 1 causes a highly bureaucratic procedure 
without any advantage for the safety measures. 
The industry proposes to minimize the license-technical and bureaucratical conditions 
considerably for the geo-technical work where are expected for human he~th or 
environment 
It is criticized in the EU guideline 90/219, article 2d, that J}le research volume is unsuitable 
as a distinguishing feature. The basis for regulation must be the risk potential of the 
. cultivated micro-organism and the objects of work. The research and production in the 
· field of fermentation with safety strains (Sicherheitsstiimmen) (GLISP) are not subjected to 
any restriction in opposition to the EU regulation. \ 
Aspects to state stimulations of innovation This point especially applies to 
Germany. Germany is the only big industrial country which does not favor R&D by 
government tax funding. Besides this, the decision in the year 1988 to tax the income of the 
inventors had a negative effect on the innovation ~tivities and resulted in only a modest 
flScal profit (tax income of 87 Mio OM/year). 
The prevalent opinion in regard to the size of the patent fees is that they are to high for the 
independent inventors as well as for small and medium-sized businesses and welfare 
enterprises. In the USA the patent fees were reduced by half for these groups in 1983. The 
result was an essential increase of patent activities among smaller fmns. 
Aspects to state policy of procurement The member states of EU should make plans 
for producing innovative products within the public sector. In Japan and in the L"SA this 
method of innovation stimulation more successfully. 
The subsidization of R&D activities is too small in the member states of EU. A big share 
of the funds for subsidy is wasted in industries which have nearly no development 
potential, for instance, agriculture or mining. 
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9 Appendix: Characteristics of the Selected Nine Companies 
Nine large companies of the chemical industry were selected for the analysis. T.o provide a 
better understanding of the analysis the following a brief characterization of these 
. companies is given:67 · 
Bayer AG Bayer was founded in 1863 for the production of aniline colorants, but later 
achieved trailblazing developments--mainly concerning pharmaceutical products and 
polyurethane chemicals. Even today, a great part of Bayer's product range are prepared 
products, such as pharmaceutical products (23 percent of the 1993 turnover with 30 percent 
as their goal for the year 2000), plant protectives and photo products. By concentrating on 
poJycarbonates, polyurethanes, and polyphosphonates, Bayer managed to avoid the typical 
problems connected with mass· production in the areas of plastics and synthetic fibres. 
BASF Aktiengesellschaft The Badische Ani1in & Soda Fabrik was also founded for the 
production of colorants. BASF was especially successful with their development of the 
Badische process~ their chlor-alkaJi electrolysis and the Haber-Bosch process. Even at a 
time when they were still with the I.~l Farben, BASF was considered the supplier of raw 
materials within the I.G. Farben, a tradition that has been preserved until the present day. 
Accordingly, in 1993, raw materials and energy accounted for 10 percent of their total 
turnover, plasqcs for 24 percent, chemicals for 13 percent, and colorants and prepared 
products for 19 percent. 
Hoechst AG The Hoechst AG was founded in the same year as Bayer. Having also started 
with colorants, their further development resembles that of Bayer. Colorants were followed 
by the successful development of numerous pharmaceutical products. After 1945, rapid 
growth temporarily made Hoechst the biggest chemical company world-wide. 
Traditionally, Hoechst is very active in the pharmaceutical business, but does not produce 
any basic petrochemicals. Hoechst is considered extremely diversified, both product-wise 
and geographically. · 
Imperial Chemical Industries PLC ICI resulted from a merger of four British 
companies in 1926, and was originally intended to present a counterpart to the German I. 
G. Farben. In the J.,930s, ICI produced the synthetic substance polyethylene. Even today, 
the diverse range of products reflects this descent from the fusion of different companies. 
Their particular strong points are paints and varnishes, as well as explosive agents. During 
the past few years, ICI carried out notably active and radical restructuring policies. In 1992, 
for instance, ICI split off their extremely profitable "bioscience activities (pharmaceutical 
industry and agriculture)" and put them into an enterprise ne}Vly founded especially for this 
purpose, "'Called Zeneca. 
67 Based on Amecke, p. 45-55 and various annual reports 
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Ciba-Geigy AG Ciba-Geigy is the_ product of a 1970 merger between CibaAG and J. R. 
Geigy~ Ciba was founded in 1884 for the production of colorants. Later on, analogue to 
Bayer and Hoechst, pharmaceutical products and plant protectives (such as DDT) were 
added. ~ .a result of the relatively limited domestic market, Ciba-Geigy is geographically 
extremely diverse and their balanced product range ensures consistently high profits. 
Sandoz AG Sandoz was founded in 1885 and, as with Ciba-Geigy, is fairly specialized in 
the pharmaceutical industry and agriculture with their pharmaceutical products constituting 
49 percent of their 1993 turnover. In addition, Sandoz is very much involved in the 
production of seeds and sp~ial food stuffs. ~ far as their chemical activities are 
concerned! their competence lies mainly in the line of colorants/pigments and chemicals for 
the textile and leather industries, as well as for the building industry. The company plans to 
concentrate solely on pharmaceutical products and nutrition in the future. The frrst radical 
step in that direction is the intended demerger of their chemical line (16 percent of the 1993 
turnover, 8200 employees) by the end of 1995. Furthermore, Sandoz plans to separate from 
its agricultural and· building chemistries as well. 
Akzo N. V. Akzo resulted from the merger of Aku (synthetic fibres) and KZO (salt) in 
1969. In the 1970s, the production of synthetic fibres still dominated Akzo, but its capacity 
overshoot soon pushed the company into a major crisis. During the past few years, 
however, Akzo's dependence on fibre production was successfully diminished. While 
fibres accounted for 52 percent Qf the turnover in 1969, it was down to less than 20 percent 
in 1993, so that today Akzo is indeed considered very competitive due to its special 
strengths in paints/varnishes and its vast pharmaceutical production (20 percent of 
turnover). In 1993, Akzo merged with the Swedish company Nobel. 
Henkel KGaA Founded in 1876, the company is still run as a family business. The 
development of Henkel has its origin in the production of detergents and bleaching soda 
and related raw materials .. To this day, Henkel's product range is characterized by 
proprietary articles, such as Persil, which was firSt introduced in 1907. 
Furthermore, Henkel is very strong in the line of fatty chemicals and adhesive substances. 
Henkel calls themselves specialists for· applied chemistry, and environmental-
consciousness constitutes an important marketing factor for Henkel. Their geographical 
diversity is very advanced. 
Solvay & Cie. Founded in 1863, the company concentrated on the production of soda. 
Nowadays, Solvay is also very active in the production of peroxides, the production and 
processing of plastics (46 percent of the 1993 turnover), as well as in alkaline chemistry. 
The _relatively low degree of diversification is a result of Solvay's policy to handle only 
products with which a strong position in the market can be obtained. Due to problems with 
mass prt>duction, the p~t few years· saw ·l¥1 expansion in the health sector (mainly 
veterinary medicine). 
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